WO2023287252A1 - Novel compound and organic light-emitting device comprising same - Google Patents

Novel compound and organic light-emitting device comprising same Download PDF

Info

Publication number
WO2023287252A1
WO2023287252A1 PCT/KR2022/010379 KR2022010379W WO2023287252A1 WO 2023287252 A1 WO2023287252 A1 WO 2023287252A1 KR 2022010379 W KR2022010379 W KR 2022010379W WO 2023287252 A1 WO2023287252 A1 WO 2023287252A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
mmol
amine
preparation example
group
Prior art date
Application number
PCT/KR2022/010379
Other languages
French (fr)
Korean (ko)
Inventor
김민준
이동훈
서상덕
김영석
Original Assignee
주식회사 엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지화학 filed Critical 주식회사 엘지화학
Priority to CN202280011343.0A priority Critical patent/CN116964060A/en
Priority claimed from KR1020220087408A external-priority patent/KR20230012442A/en
Publication of WO2023287252A1 publication Critical patent/WO2023287252A1/en

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00—Energy generation through renewable energy sources
    • Y02E10/50—Photovoltaic [PV] energy
    • Y02E10/549—Organic PV cells

Definitions

  • the present invention relates to a novel compound and an organic light emitting device including the same.
  • the organic light emitting phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material.
  • An organic light emitting device using an organic light emitting phenomenon has a wide viewing angle, excellent contrast, and a fast response time, and has excellent luminance, driving voltage, and response speed characteristics, and thus many studies are being conducted.
  • An organic light emitting device generally has a structure including an anode, a cathode, and an organic material layer between the anode and the cathode.
  • the organic material layer is often composed of a multi-layered structure composed of different materials, and may include, for example, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer.
  • a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic material layer, and when the injected holes and electrons meet, excitons are formed. When it falls back to the ground state, it glows.
  • the present invention provides a novel organic light emitting device material that can be used in an organic light emitting device and can be used in a solution process at the same time.
  • Patent Document 0001 Korean Patent Publication No. 10-2000-0051826
  • the present invention relates to a novel compound and an organic light emitting device including the same.
  • the present invention provides a compound represented by Formula 1 below:
  • One of X 1 to X 10 is N, the other is CR 1 ,
  • R 1 is a substituent represented by Formula 2 below, the others are hydrogen or deuterium,
  • L 1 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
  • L 2 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
  • L 3 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
  • Ar 1 is a substituted or unsubstituted C 6-60 aryl; or a substituted or unsubstituted C 5-60 heteroaryl;
  • Ar 2 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl.
  • the present invention is a first electrode; a second electrode provided to face the first electrode; and an organic material layer provided between the first electrode and the second electrode, wherein the organic material layer includes the compound represented by Chemical Formula 1.
  • the organic material layer including the compound may be an electroluminescent layer.
  • the compound represented by Chemical Formula 1 may be used as a material for an organic material layer of an organic light emitting device, and may improve efficiency, low driving voltage, and/or lifetime characteristics of an organic light emitting device.
  • the compound represented by Chemical Formula 1 may be used as a material for hole injection, hole transport, hole injection and transport, electron suppression, light emission, electron transport, or electron injection.
  • FIG. 1 shows an example of an organic light emitting device composed of a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4.
  • FIG. 2 is an example of an organic light emitting device composed of a substrate (1), an anode (2), a hole injection layer (5), a hole transport layer (6), a light emitting layer (7), an electron injection and transport layer (8) and a cathode (4). is shown.
  • substituted or unsubstituted means deuterium; halogen group; cyano group; nitro group; hydroxy group; carbonyl group; ester group; imide group; amino group; phosphine oxide group; alkoxy group; aryloxy group; Alkyl thioxy group; Arylthioxy group; an alkyl sulfoxy group; aryl sulfoxy groups; silyl group; boron group; an alkyl group; cycloalkyl group; alkenyl group; aryl group; aralkyl group; Aralkenyl group; Alkyl aryl group; Alkylamine group; Aralkylamine group; heteroarylamine group; Arylamine group; Arylphosphine group; Or substituted or unsubstituted with one or more substituents selected from the group consisting of heteroaryl containing at least one of N, O, and S atoms, or substituted or unsubstituted
  • a substituent in which two or more substituents are connected may be a biphenyl group. That is, the biphenyl group may be an aryl group or may be interpreted as a substituent in which two phenyl groups are connected.
  • the number of carbon atoms of the carbonyl group is not particularly limited, but is preferably 1 to 40 carbon atoms. Specifically, it may be a compound having the following structure, but is not limited thereto.
  • the ester group may be substituted with an aryl group having 6 to 25 carbon atoms or a straight-chain, branched-chain or cyclic chain alkyl group having 1 to 25 carbon atoms in the ester group.
  • it may be a compound of the following structural formula, but is not limited thereto.
  • the number of carbon atoms of the imide group is not particularly limited, but is preferably 1 to 25 carbon atoms. Specifically, it may be a compound having the following structure, but is not limited thereto.
  • the silyl group is specifically a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, and the like. but not limited to
  • the boron group specifically includes a trimethyl boron group, a triethyl boron group, a t-butyldimethyl boron group, a triphenyl boron group, a phenyl boron group, but is not limited thereto.
  • examples of the halogen group include fluorine, chlorine, bromine or iodine.
  • the alkyl group may be straight-chain or branched-chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 40. According to one embodiment, the number of carbon atoms of the alkyl group is 1 to 20. According to another exemplary embodiment, the number of carbon atoms of the alkyl group is 1 to 10. According to another exemplary embodiment, the alkyl group has 1 to 6 carbon atoms.
  • alkyl group examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n -pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl , n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl
  • the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. According to one embodiment, the alkenyl group has 2 to 20 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 10 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 6 carbon atoms.
  • Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1- Butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-( naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, stilbenyl group, styrenyl group, etc., but is not limited thereto.
  • the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and according to an exemplary embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 20. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 6.
  • the aryl group is not particularly limited, but preferably has 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 30. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 20.
  • the aryl group may be a phenyl group, a biphenyl group, a terphenyl group, etc. as a monocyclic aryl group, but is not limited thereto.
  • the polycyclic aryl group may be a naphthyl group, anthracenyl group, phenanthrenyl group, pyrenyl group, perylenyl group, chrysenyl group, fluorenyl group, etc., but is not limited thereto.
  • the fluorenyl group may be substituted, and two substituents may be bonded to each other to form a spiro structure.
  • the fluorenyl group is substituted, etc.
  • it is not limited thereto.
  • heteroaryl is a heteroaryl containing at least one of O, N, Si, and S as a heterogeneous element, and the number of carbon atoms is not particularly limited, but preferably has 2 to 60 carbon atoms.
  • the heteroaryl include xanthene, thioxanthen, thiophene, furan, pyrrole, imidazole, thiazole, oxazole, oxadiazole, triazole, pyridyl, bipyridyl, Pyrimidyl group, triazine group, acridyl group, pyridazine group, pyrazinyl group, quinolinyl group, quinazoline group, quinoxalinyl group, phthalazinyl group, pyridopyrimidinyl group, pyridopyrazinyl group, pyrazino Pyrazinyl group, isoquinoline group, indole group, carbazo
  • an aralkyl group, an aralkenyl group, an alkylaryl group, an arylamine group, and an aryl group among arylsilyl groups are the same as the examples of the aryl group described above.
  • the alkyl group among the aralkyl group, the alkylaryl group, and the alkylamine group is the same as the examples of the above-mentioned alkyl group.
  • the description of the above-described heteroaryl may be applied to the heteroaryl among heteroarylamines.
  • the alkenyl group among the aralkenyl groups is the same as the examples of the alkenyl group described above.
  • the description of the aryl group described above may be applied except that the arylene is a divalent group.
  • the description of heteroaryl described above may be applied except that the heteroarylene is a divalent group.
  • the hydrocarbon ring is not a monovalent group, and the description of the aryl group or cycloalkyl group described above may be applied, except that the hydrocarbon ring is formed by combining two substituents.
  • the heterocyclic group is not a monovalent group, and the description of the above-described heteroaryl may be applied, except that it is formed by combining two substituents.
  • the present invention provides a compound represented by Formula 1 above.
  • Ar 1 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl.
  • Ar 1 is phenyl; biphenylyl; terphenylyl; naphthyl; phenanthrene; (phenyl) naphthyl; (naphthyl)phenyl; 9,9-dimethylfluorenyl; 9,9-diphenylfluorenyl; 9,9'-spirobi[9H-fluorene]yl;dibenzofuranyl;dibenzothiophenyl;9-phenyl-carbazolyl; or 9-naphthyl-carbazolyl.
  • Ar 2 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl.
  • Ar 2 is phenyl; biphenylyl; terphenylyl; naphthyl; phenanthrene; (phenyl) naphthyl; (naphthyl)phenyl; 9,9-dimethylfluorenyl; 9,9-diphenylfluorenyl; 9,9'-spirobi[9H-fluorene]yl;dibenzofuranyl;dibenzothiophenyl;9-phenyl-carbazolyl; or 9-naphthyl-carbazolyl.
  • L 1 is a direct bond; Substituted or unsubstituted C 6-60 arylene; Or a substituted or unsubstituted C 5-60 heteroarylene.
  • L 1 is a direct bond; or phenylene.
  • L 2 is a direct bond; Substituted or unsubstituted C 6-60 arylene; Or a substituted or unsubstituted C 5-60 heteroarylene.
  • L 2 is a direct bond; phenylene; terphenylylene; biphenylylene; 9,9-dimethylfluorenylene; 9,9-diphenylfluorenylene; or naphthylene.
  • L 3 is a direct bond; Substituted or unsubstituted C 6-60 arylene; Or a substituted or unsubstituted C 5-60 heteroarylene.
  • L 3 is a direct bond; phenylene; terphenylylene; biphenylylene; 9,9-dimethylfluorenylene; 9,9-diphenylfluorenylene; or naphthylene.
  • CR 1 represented by Formula 2 may be attached to one of X 1 to X 4 in Formula 1.
  • the present invention provides a method for preparing the compound represented by Formula 1 as shown in Reaction Scheme 1 below.
  • X 1 to X 10 , L 1 , L 2 , L 3 , Ar 1 , and Ar 2 are defined as in Formulas 1 and 2.
  • Y is halogen, preferably chloro.
  • Reaction Scheme 1 is preferably carried out in the presence of a palladium catalyst and a base, and the preparation method may be more specific in a synthesis example to be described later.
  • the present invention provides an organic light emitting device including the compound represented by Formula 1 above.
  • the present invention provides a first electrode; a second electrode provided to face the first electrode; and one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the compound represented by Chemical Formula 1. .
  • the organic material layer of the organic light emitting device of the present invention may have a single-layer structure, or may have a multi-layer structure in which two or more organic material layers are stacked.
  • the organic light emitting device of the present invention may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, a hole blocking layer, an electron transport layer, an electron injection layer, and the like as organic layers.
  • the structure of the organic light emitting device is not limited thereto and may include fewer organic layers.
  • the organic material layer may include a hole injection layer, a hole transport layer, or a layer that simultaneously injects and transports holes, and the hole injection layer, the hole transport layer, or a layer that simultaneously injects and transports holes is represented by Formula 1 above. may contain the indicated compounds.
  • the organic material layer may include a light emitting layer, and the light emitting layer may include the compound represented by Chemical Formula 1.
  • the organic material layer may include a hole blocking layer, an electron transport layer, an electron injection layer, or a layer that simultaneously transports and injects electrons, and the hole blocking layer, the electron transport layer, the electron injection layer, or the electron transport and electron injection layer.
  • the layer to be simultaneously injected may include the compound represented by Chemical Formula 1 above.
  • the organic material layer may include a light emitting layer and an electron injection and transport layer
  • the electron injection and transport layer may include the compound represented by Chemical Formula 1.
  • the organic light emitting device according to the present invention may be a normal type organic light emitting device in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate.
  • the organic light emitting device according to the present invention may be an organic light emitting device of an inverted type in which a cathode, one or more organic material layers, and an anode are sequentially stacked on a substrate.
  • FIGS. 1 and 2 the structure of an organic light emitting device according to an embodiment of the present invention is illustrated in FIGS. 1 and 2 .
  • FIG. 1 shows an example of an organic light emitting device composed of a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4.
  • FIG. 2 is an example of an organic light emitting device composed of a substrate (1), an anode (2), a hole injection layer (5), a hole transport layer (6), a light emitting layer (7), an electron injection and transport layer (8) and a cathode (4). is shown.
  • the compound represented by Chemical Formula 1 may be included in the light emitting layer.
  • the organic light emitting device according to the present invention may be manufactured using materials and methods known in the art, except that at least one of the organic layers includes the compound represented by Chemical Formula 1. Also, when the organic light emitting device includes a plurality of organic material layers, the organic material layers may be formed of the same material or different materials.
  • the organic light emitting device may be manufactured by sequentially stacking an anode, an organic material layer, and a cathode on a substrate.
  • a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation, depositing a metal or a metal oxide having conductivity or an alloy thereof on the substrate to form an anode
  • PVD physical vapor deposition
  • depositing a metal or a metal oxide having conductivity or an alloy thereof depositing a metal or a metal oxide having conductivity or an alloy thereof on the substrate to form an anode
  • an organic material layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer thereon, and depositing a material that can be used as a cathode thereon, it can be prepared.
  • an organic light emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
  • the compound represented by Chemical Formula 1 may be formed as an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device.
  • the solution coating method means spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating, etc., but is not limited to these.
  • an organic light emitting device may be manufactured by sequentially depositing an organic material layer and an anode material on a substrate from a cathode material (WO 2003/012890).
  • the manufacturing method is not limited thereto.
  • the first electrode is an anode and the second electrode is a cathode, or the first electrode is a cathode and the second electrode is an anode.
  • the cathode material a material having a high work function is generally preferred so that holes can be smoothly injected into the organic material layer.
  • the cathode material include metals such as vanadium, chromium, copper, zinc, and gold or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; conductive compounds such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline; and the like, but are not limited thereto.
  • the cathode material is preferably a material having a small work function so as to easily inject electrons into the organic material layer.
  • Specific examples of the anode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; There are multi-layered materials such as LiF/Al or LiO 2 /Al, but are not limited thereto.
  • the hole injection layer is a layer for injecting holes from the electrode, and the hole injection material has the ability to transport holes and has a hole injection effect at the anode, an excellent hole injection effect for the light emitting layer or the light emitting material, and generated in the light emitting layer
  • a compound that prevents migration of excitons to the electron injecting layer or electron injecting material and has excellent thin film formation ability is preferred. It is preferable that the highest occupied molecular orbital (HOMO) of the hole injection material is between the work function of the anode material and the HOMO of the surrounding organic layer.
  • HOMO highest occupied molecular orbital
  • the hole injection material include metal porphyrins, oligothiophenes, arylamine-based organic materials, hexanitrilehexaazatriphenylene-based organic materials, quinacridone-based organic materials, and perylene-based organic materials. of organic matter, anthraquinone, and polyaniline and polythiophene-based conductive compounds, but are not limited thereto.
  • the hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer.
  • the hole transport material is a material that can receive holes from the anode or the hole injection layer and transfer them to the light emitting layer, and has high hole mobility. material is suitable. Specific examples include, but are not limited to, arylamine-based organic materials, conductive compounds, and block copolymers having both conjugated and non-conjugated parts.
  • the light emitting material is a material capable of emitting light in the visible ray region by receiving and combining holes and electrons from the hole transport layer and the electron transport layer, respectively, and a material having good quantum efficiency for fluorescence or phosphorescence is preferable.
  • Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); carbazole-based compounds; dimerized styryl compounds; BAlq; 10-hydroxybenzoquinoline-metal compounds; compounds of the benzoxazole, benzthiazole and benzimidazole series; poly(p-phenylenevinylene) (PPV)-based polymers; spiro compounds; Polyfluorene, rubrene, etc., but are not limited thereto.
  • the electron blocking layer is a layer placed between the hole transport layer and the light emitting layer to prevent electrons injected from the cathode from passing to the hole transport layer without recombination in the light emitting layer, and is also called an electron blocking layer.
  • a material having a smaller electron affinity than the electron transport layer is preferable for the electron blocking layer.
  • the compound represented by Chemical Formula 1 may be included as a material of the electron blocking layer.
  • the light emitting layer may include a host material and a dopant material.
  • the host material the compound represented by Chemical Formula 1 may be used.
  • a condensed aromatic ring derivative or a compound containing a heterocyclic ring can be used as a host material that can be further used.
  • condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc.
  • heterocyclic-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type furan compounds, pyrimidine derivatives, etc., but are not limited thereto.
  • Dopant materials include aromatic amine derivatives, strylamine compounds, boron complexes, fluoranthene compounds, metal complexes, and the like.
  • aromatic amine derivatives are condensed aromatic ring derivatives having a substituted or unsubstituted arylamino group, such as pyrene, anthracene, chrysene, periplanthene, etc.
  • styrylamine compounds include substituted or unsubstituted arylamine is substituted with at least one arylvinyl group, wherein one or two or more substituents selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group, and an arylamino group are substituted or unsubstituted.
  • substituents selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group, and an arylamino group are substituted or unsubstituted.
  • metal complexes include, but are not limited to, iridium complexes and platinum complexes.
  • Dp-1 to Dp-38 may be mentioned, but is not limited thereto.
  • the electron transport layer is a layer that receives electrons from the electron injection layer and transports electrons to the light emitting layer.
  • the electron transport material a material capable of receiving electrons from the cathode and transferring them to the light emitting layer is suitable. Do. Specific examples include Al complexes of 8-hydroxyquinoline; Complexes containing Alq 3 ; organic radical compounds; hydroxyflavone-metal complexes and the like, but are not limited thereto.
  • the electron transport layer can be used with any desired cathode material as used according to the prior art.
  • suitable cathode materials are conventional materials having a low work function followed by a layer of aluminum or silver. Specifically cesium, barium, calcium, ytterbium and samarium, followed in each case by a layer of aluminum or silver.
  • the electron injection layer is a layer for injecting electrons from an electrode, has the ability to transport electrons, has an excellent electron injection effect from a cathode, an excellent electron injection effect for a light emitting layer or a light emitting material, and injects holes of excitons generated in the light emitting layer.
  • a compound that prevents migration to a layer and has excellent thin film forming ability is preferred. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preonylidene methane, anthrone, etc. and their derivatives, metals complex compounds and nitrogen-containing 5-membered ring derivatives, but are not limited thereto.
  • Examples of the metal complex compound include 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato) aluminum, tris(2-methyl-8-hydroxyquinolinato) aluminum, tris(8-hydroxyquinolinato) gallium, bis(10-hydroxybenzo[h] Quinolinato) beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( There are o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtolato)aluminum, and bis(2-methyl-8-quinolinato)(2-naphtolato)gallium. Not limited to this.
  • the "electron injection and transport layer” is a layer that performs both the roles of the electron injection layer and the electron transport layer, and materials that play the role of each layer may be used alone or in combination, but are limited thereto. It doesn't work.
  • the compound represented by Formula 1 may be included as a material for the electron injection and transport layer.
  • the organic light emitting device according to the present invention may be a bottom emission device, a top emission device, or a double-sided light emitting device, and in particular, may be a bottom emission device requiring relatively high light emitting efficiency.
  • the compound according to the present invention may be included in an organic solar cell or an organic transistor in addition to an organic light emitting device.
  • 3-Bromo-2-chloropyridin-4-amine (15 g, 72.3 mmol) and (1-methoxynaphthalen-2-yl) boronic acid (15.3 g, 75.9 mmol) were dissolved in tetrahydrofuran (300 ml). It was added and stirred and refluxed. Thereafter, potassium carbonate (30 g, 216.9 mmol) was dissolved in water (90 ml), and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.7 mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled.
  • Compound A-a-2 was prepared in the same manner as in Preparation Example 1, except that 5-bromo-2-chloropyridin-4-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-a-3 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-5-chloropyridin-4-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-b-1 was prepared in the same manner as in Preparation Example 1, except that 4-bromo-5-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-b-2 was prepared in the same manner as in Preparation Example 1, except that 4-bromo-6-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-b-3 was prepared in the same manner as in Preparation Example 1, except that 4-bromo-2-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-c-1 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-4-chloropyridin-2-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-c-2 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-5-chloropyridin-2-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-c-3 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-6-chloropyridin-2-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-d-1 was prepared in the same manner as in Preparation Example 1, except that 2-bromo-4-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-d-2 was prepared in the same manner as in Preparation Example 1, except that 2-bromo-5-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound A-d-3 was prepared in the same manner as in Preparation Example 1, except that 2-bromo-6-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
  • Compound B-a-2 was prepared in the same manner as in Preparation Example 13, except that (5-chloro-2-methoxyphenyl)boronic acid was used instead of (2-chloro-6-methoxyphenyl)boronic acid.
  • Compound B-a-3 was prepared in the same manner as in Preparation Example 13, except that (4-chloro-2-methoxyphenyl)boronic acid was used instead of (2-chloro-6-methoxyphenyl)boronic acid.
  • Compound B-a-4 was prepared in the same manner as in Preparation Example 13, except that (3-chloro-2-methoxyphenyl)boronic acid was used instead of (2-chloro-6-methoxyphenyl)boronic acid.
  • Compound B-b-1 was prepared in the same manner as in Preparation Example 13, except that 7-bromoisoquinolin-8-amine was used instead of 7-bromoquinolin-8-amine.
  • Compound B-c-1 was prepared in the same manner as in Preparation Example 13, except that 6-bromoisoquinolin-5-amine was used instead of 7-bromoquinolin-8-amine.
  • Compound B-d-1 was prepared in the same manner as in Preparation Example 13, except that 6-bromoquinolin-5-amine was used instead of 7-bromoquinolin-8-amine.
  • Compound B-e-1 was prepared in the same manner as in Preparation Example 13, except that 3-bromoquinolin-4-amine was used instead of 7-bromoquinolin-8-amine.
  • Compound B-f-1 was prepared in the same manner as in Preparation Example 13, except that 3-bromoisoquinolin-4-amine was used instead of 7-bromoquinolin-8-amine.
  • 2-Bromopyridin-3-amine (15 g, 86.7 mmol) and (7-chloro-1-methoxynaphthalen-2-yl) boronic acid (21.5 g, 91 mmol) were dissolved in tetrahydrofuran (300 ml). It was added and stirred and refluxed. After dissolving potassium carbonate (35.9 g, 260.1 mmol) in water (108 ml), it was added, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.9 mmol) was added. After reacting for 3 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer.
  • Compound C-b-1 was prepared in the same manner as in Preparation Example 37, except that 3-bromopyridin-4-amine was used instead of 2-bromopyridin-3-amine.
  • 3-bromopyridin-4-amine is used instead of 2-bromopyridin-3-amine, and (8-chloro-1-methoxy Compound C-b-6 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
  • Compound C-c-1 was prepared in the same manner as in Preparation Example 37, except that 4-bromopyridin-3-amine was used instead of 2-bromopyridin-3-amine.
  • Compound C-d-1 was prepared in the same manner as in Preparation Example 37, except that 3-bromopyridin-2-amine was used instead of 2-bromopyridin-3-amine.
  • 3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, and (6-chloro-1-methoxy Compound C-d-2 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
  • 3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, and (5-chloro-1-methoxy Compound C-d-3 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
  • 3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, and (8-chloro-1-methoxy Compound C-d-6 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
  • 3-Bromo-6-chloroisoquinolin-4-amine (15 g, 58.2 mmol) and (2-methoxyphenyl) boronic acid (9.3 g, 61.2 mmol) were added to tetrahydrofuran (300 ml), stirred and refluxed. Thereafter, potassium carbonate (24.2 g, 174.7 mmol) was dissolved in water (72 ml), and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.3 g, 0.6 mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and an organic layer and an aqueous layer were separated, and the organic layer was distilled.
  • Compound D-a-2 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-7-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-a-3 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-8-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-a-4 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-1-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-a-5 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-5-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-b-1 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-2-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-b-2 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-3-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-b-3 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-4-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-b-4 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-5-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-b-5 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-6-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-c-1 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-3-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-c-2 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-4-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-c-3 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-5-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-c-4 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-6-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-c-5 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-1-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-d-1 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-3-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-d-2 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-1-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-d-3 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-8-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-d-4 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-7-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-d-5 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-4-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-e-1 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-3-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-e-2 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-2-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-e-3 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-8-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-e-4 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-7-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-e-5 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-4-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-f-1 was prepared in the same manner as in Preparation Example 61, except for using 3-bromo-6-chloroisoquinolin-4-amine instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-f-2 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-7-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-f-3 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-8-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-f-4 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-2-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • Compound D-f-5 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-5-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
  • compound Aa-2 (10 g, 39.4 mmol), amine 1 (16.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Aa-3 (10 g, 39.4 mmol), amine 2 (13.8 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ac-2 (10 g, 39.4 mmol), amine 7 (15.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ac-2 (10 g, 39.4 mmol), amine 8 (13.9 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ac-2 (10 g, 39.4 mmol), amine 9 (12.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ad-1 (10 g, 39.4 mmol), amine 10 (12.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ad-2 (10 g, 39.4 mmol), amine 11 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ad-3 (10 g, 39.4 mmol), amine 12 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ad-3 (10 g, 39.4 mmol), amine 13 (14.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Ad-3 (10 g, 39.4 mmol), amine 14 (16.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bb-2 (10 g, 39.4 mmol), amine 17 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bc-1 (10 g, 39.4 mmol), amine 18 (13.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bc-3 (10 g, 39.4 mmol), amine 19 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bd-1 (10 g, 39.4 mmol), amine 20 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bd-2 (10 g, 39.4 mmol), amine 15 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bd-3 (10 g, 39.4 mmol), amine 21 (14.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bd-3 (10 g, 39.4 mmol), amine 22 (15.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bd-3 (10 g, 39.4 mmol), amine 23 (13.9 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bd-4 (10 g, 39.4 mmol), amine 24 (14.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Be-1 (10 g, 39.4 mmol), amine 25 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Be-4 (10 g, 39.4 mmol), amine 26 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Be-4 (10 g, 39.4 mmol), amine 27 (18.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bf-2 (10 g, 39.4 mmol), amine 28 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Bf-3 (10 g, 39.4 mmol), amine 29 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Cb-5 (10 g, 39.4 mmol), amine 32 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Cc-4 (10 g, 39.4 mmol), amine 35 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Dd-1 (10 g, 39.4 mmol), amine 20 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • compound Dd-3 (10 g, 39.4 mmol), amine 20 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure.
  • a glass substrate coated with indium tin oxide (ITO) with a thickness of 1,000 ⁇ was put in distilled water in which detergent was dissolved and washed with ultrasonic waves.
  • ITO indium tin oxide
  • a Fischer Co. product was used as the detergent
  • distilled water filtered through a second filter of a Millipore Co. product was used as the distilled water.
  • ultrasonic cleaning was performed for 10 minutes.
  • ultrasonic cleaning was performed with solvents such as isopropyl alcohol, acetone, and methanol, dried, and transported to a plasma cleaner.
  • solvents such as isopropyl alcohol, acetone, and methanol
  • the following compound HI-1 was formed to a thickness of 1150 ⁇ as a hole injection layer on the prepared ITO transparent electrode, but the following compound A-1 was p-doped at a concentration of 1.5%.
  • the following HT-1 compound was vacuum deposited to form a hole transport layer having a film thickness of 800 ⁇ .
  • a second hole transport layer was formed on the hole transport layer by vacuum depositing the following compound 1 to a film thickness of 150 ⁇ .
  • the following RH-1 compound as a host and the following Dp-7 compound as a dopant were vacuum deposited at a weight ratio of 98:2 to form a red light emitting layer having a thickness of 400 ⁇ .
  • a hole blocking layer was formed on the light emitting layer by vacuum depositing the following HB-1 compound to a film thickness of 30 ⁇ . Subsequently, the following ET-1 compound and the following LiQ compound were vacuum deposited at a weight ratio of 2:1 on the hole blocking layer to form an electron injection and transport layer with a thickness of 300 ⁇ .
  • a negative electrode was formed by sequentially depositing lithium fluoride (LiF) to a thickness of 12 ⁇ and aluminum to a thickness of 1,000 ⁇ on the electron injection and transport layer.
  • the deposition rate of the organic material was maintained at 0.4 to 0.7 ⁇ /sec
  • the deposition rate of lithium fluoride on the anode was 0.3 ⁇ /sec
  • the deposition rate of aluminum was 2 ⁇ /sec
  • the vacuum level during deposition was 2 ⁇ 10 Maintaining -7 to 5 ⁇ 10 -6 torr, an organic light emitting device was fabricated.
  • An organic light emitting device was manufactured in the same manner as in Example 1, except that the compound shown in Table 1 was used instead of Compound 1 in the organic light emitting device of Example 1.
  • An organic light emitting device was manufactured in the same manner as in Comparative Example 1, except that the compound shown in Table 1 was used instead of Compound 1 in the organic light emitting device of Example 1.
  • the lifetime T95 means the time required for the luminance to decrease from the initial luminance (6000 nit) to 95%.
  • the red organic light emitting device of Example 1 uses materials widely used in the prior art, and has a structure in which Dp-7 is used as a dopant for the red light emitting layer.
  • organic light emitting diodes were prepared using C-1 to C-12 instead of Compound 1. Looking at the results of Tables 1 to 4, when the compound of the present invention was used as the second hole hydrogen layer, the driving voltage was significantly lowered compared to the comparative example material, and the efficiency was also increased, so that the host to the red dopant It was found that the energy transfer was well done.
  • the lifetime characteristics can be greatly improved while maintaining high efficiency. It can be determined that this is because the compound of the present invention has higher electron and hole stability than the comparative compound. In conclusion, it can be confirmed that the driving voltage, luminous efficiency and lifetime characteristics of the organic light emitting device can be improved when the compound of the present invention is used as the second hole transport layer.
  • substrate 2 anode

Abstract

The present invention provides a novel compound and an organic light-emitting device comprising same.

Description

신규한 화합물 및 이를 이용한 유기 발광 소자Novel compound and organic light emitting device using the same
관련 출원(들)과의 상호 인용Cross-citation with related application(s)
본 출원은 2021년 7월 15일자 한국 특허 출원 제10-2021-0093023호 및 2022년 7월 15일자 한국 특허 출원 제10-2022-0087408호에 기초한 우선권의 이익을 주장하며, 해당 한국 특허 출원들의 문헌에 개시된 모든 내용은 본 명세서의 일부로서 포함된다.This application claims the benefit of priority based on Korean Patent Application No. 10-2021-0093023 dated July 15, 2021 and Korean Patent Application No. 10-2022-0087408 dated July 15, 2022, and All material disclosed in the literature is incorporated as part of this specification.
본 발명은 신규한 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present invention relates to a novel compound and an organic light emitting device including the same.
일반적으로 유기 발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기 발광 현상을 이용하는 유기 발광 소자는 넓은 시야각, 우수한 콘트라스트, 빠른 응답 시간을 가지며, 휘도, 구동 전압 및 응답 속도 특성이 우수하여 많은 연구가 진행되고 있다. In general, the organic light emitting phenomenon refers to a phenomenon in which electrical energy is converted into light energy using an organic material. An organic light emitting device using an organic light emitting phenomenon has a wide viewing angle, excellent contrast, and a fast response time, and has excellent luminance, driving voltage, and response speed characteristics, and thus many studies are being conducted.
유기 발광 소자는 일반적으로 양극과 음극 및 상기 양극과 음극 사이에 유기물층을 포함하는 구조를 가진다. 상기 유기물층은 유기 발광 소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층 등으로 이루어질 수 있다. 이러한 유기 발광 소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. An organic light emitting device generally has a structure including an anode, a cathode, and an organic material layer between the anode and the cathode. In order to increase the efficiency and stability of the organic light emitting device, the organic material layer is often composed of a multi-layered structure composed of different materials, and may include, for example, a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. In the structure of this organic light emitting device, when a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic material layer, and when the injected holes and electrons meet, excitons are formed. When it falls back to the ground state, it glows.
상기와 같은 유기 발광 소자에 사용되는 유기물에 대하여 새로운 재료의 개발이 지속적으로 요구되고 있다.The development of new materials for organic materials used in the organic light emitting device as described above is continuously required.
한편, 최근에는 공정 비용 절감을 위하여 기존의 증착 공정 대신 용액 공정, 특히 잉크젯 공정을 이용한 유기 발광 소자가 개발되고 있다. 초창기에는 모든 유기 발광 소자 층을 용액 공정으로 코팅하여 유기 발광 소자를 개발하려 하였으나 현재 기술로는 한계가 있어, 정구조 형태에서 HIL, HTL, EML만을 용액 공정으로 진행하고 추후 공정은 기존의 증착 공정을 활용하는 하이브리드(hybrid) 공정이 연구 중이다. Meanwhile, in recent years, an organic light emitting device using a solution process, particularly an inkjet process, instead of a conventional deposition process has been developed to reduce process costs. In the early days, an attempt was made to develop an organic light emitting device by coating all organic light emitting device layers with a solution process, but the current technology has limitations, so only HIL, HTL, and EML in the form of a regular structure are carried out as a solution process, and the subsequent process is the existing deposition process A hybrid process that utilizes is being studied.
이에 본 발명에서는 유기 발광 소자에 사용될 수 있으면서 동시에 용액 공정에 사용 가능한 신규한 유기 발광 소자의 소재를 제공한다.Accordingly, the present invention provides a novel organic light emitting device material that can be used in an organic light emitting device and can be used in a solution process at the same time.
[선행기술문헌][Prior art literature]
[특허문헌][Patent Literature]
(특허문헌 0001) 한국특허 공개번호 제10-2000-0051826호(Patent Document 0001) Korean Patent Publication No. 10-2000-0051826
본 발명은 신규한 화합물 및 이를 포함하는 유기 발광 소자에 관한 것이다. The present invention relates to a novel compound and an organic light emitting device including the same.
본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다: The present invention provides a compound represented by Formula 1 below:
[화학식 1][Formula 1]
Figure PCTKR2022010379-appb-img-000001
Figure PCTKR2022010379-appb-img-000001
상기 화학식 1에서, In Formula 1,
X1 내지 X10 중 하나는 N이고, 나머지는 CR1이고,One of X 1 to X 10 is N, the other is CR 1 ,
R1 중 하나는 하기 화학식 2로 표시되는 치환기이고, 나머지는 수소, 또는 중수소이고, One of R 1 is a substituent represented by Formula 2 below, the others are hydrogen or deuterium,
[화학식 2][Formula 2]
Figure PCTKR2022010379-appb-img-000002
Figure PCTKR2022010379-appb-img-000002
상기 화학식 2에서,In Formula 2,
L1은 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이고,L 1 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
L2는 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이고,L 2 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
L3는 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이고L 3 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
Ar1은 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된 C5-60 헤테로아릴이고,Ar 1 is a substituted or unsubstituted C 6-60 aryl; or a substituted or unsubstituted C 5-60 heteroaryl;
Ar2는 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된 C5-60 헤테로아릴이다.Ar 2 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl.
또한, 본 발명은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층은 상기 화학식 1로 표시되는 화합물을 포함하는, 유기 발광 소자를 제공한다. 구체적으로 상기 화합물을 포함하는 유기물층은 전자발광층일 수 있다.In addition, the present invention is a first electrode; a second electrode provided to face the first electrode; and an organic material layer provided between the first electrode and the second electrode, wherein the organic material layer includes the compound represented by Chemical Formula 1. Specifically, the organic material layer including the compound may be an electroluminescent layer.
상술한 화학식 1로 표시되는 화합물은 유기 발광 소자의 유기물층의 재료로서 사용될 수 있으며, 유기 발광 소자에서 효율의 향상, 낮은 구동전압 및/또는 수명 특성을 향상시킬 수 있다. 특히, 상술한 화학식 1로 표시되는 화합물은 정공주입, 정공수송, 정공주입 및 수송, 전자억제, 발광, 전자수송, 또는 전자주입 재료로 사용될 수 있다.The compound represented by Chemical Formula 1 may be used as a material for an organic material layer of an organic light emitting device, and may improve efficiency, low driving voltage, and/or lifetime characteristics of an organic light emitting device. In particular, the compound represented by Chemical Formula 1 may be used as a material for hole injection, hole transport, hole injection and transport, electron suppression, light emission, electron transport, or electron injection.
도 1은 기판(1), 양극(2), 발광층(3), 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다. 1 shows an example of an organic light emitting device composed of a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4.
도 2는 기판 (1), 양극(2), 정공주입층(5), 정공수송층(6), 발광층(7), 전자주입 및 수송층(8) 및 음극(4)로 이루어진 유기 발광 소자의 예를 도시한 것이다. 2 is an example of an organic light emitting device composed of a substrate (1), an anode (2), a hole injection layer (5), a hole transport layer (6), a light emitting layer (7), an electron injection and transport layer (8) and a cathode (4). is shown.
이하, 본 발명의 이해를 돕기 위하여 보다 상세히 설명한다.Hereinafter, in order to aid understanding of the present invention, it will be described in more detail.
(용어의 정의)(Definition of Terms)
본 명세서에서,
Figure PCTKR2022010379-appb-img-000003
또는
Figure PCTKR2022010379-appb-img-000004
는 다른 치환기에 연결되는 결합을 의미한다.In this specification,
Figure PCTKR2022010379-appb-img-000003
or
Figure PCTKR2022010379-appb-img-000004
means a bond connected to another substituent.
본 명세서에서 "치환 또는 비치환된" 이라는 용어는 중수소; 할로겐기; 시아노기; 니트로기; 히드록시기; 카보닐기; 에스테르기; 이미드기; 아미노기; 포스핀옥사이드기; 알콕시기; 아릴옥시기; 알킬티옥시기; 아릴티옥시기; 알킬술폭시기; 아릴술폭시기; 실릴기; 붕소기; 알킬기; 사이클로알킬기; 알케닐기; 아릴기; 아르알킬기; 아르알케닐기; 알킬아릴기; 알킬아민기; 아랄킬아민기; 헤테로아릴아민기; 아릴아민기; 아릴포스핀기; 또는 N, O 및 S 원자 중 1개 이상을 포함하는 헤테로아릴로 이루어진 군에서 선택된 1개 이상의 치환기로 치환 또는 비치환되거나, 상기 예시된 치환기 중 2 이상의 치환기가 연결된 치환 또는 비치환된 것을 의미한다. 예컨대, "2 이상의 치환기가 연결된 치환기"는 비페닐기일 수 있다. 즉, 비페닐이기는 아릴기일 수도 있고, 2개의 페닐기가 연결된 치환기로 해석될 수도 있다.In this specification, the term "substituted or unsubstituted" means deuterium; halogen group; cyano group; nitro group; hydroxy group; carbonyl group; ester group; imide group; amino group; phosphine oxide group; alkoxy group; aryloxy group; Alkyl thioxy group; Arylthioxy group; an alkyl sulfoxy group; aryl sulfoxy groups; silyl group; boron group; an alkyl group; cycloalkyl group; alkenyl group; aryl group; aralkyl group; Aralkenyl group; Alkyl aryl group; Alkylamine group; Aralkylamine group; heteroarylamine group; Arylamine group; Arylphosphine group; Or substituted or unsubstituted with one or more substituents selected from the group consisting of heteroaryl containing at least one of N, O, and S atoms, or substituted or unsubstituted with two or more substituents linked to each other among the substituents exemplified above. . For example, "a substituent in which two or more substituents are connected" may be a biphenyl group. That is, the biphenyl group may be an aryl group or may be interpreted as a substituent in which two phenyl groups are connected.
본 명세서에서 카보닐기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 40인 것이 바람직하다. 구체적으로 하기와 같은 구조의 화합물이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the number of carbon atoms of the carbonyl group is not particularly limited, but is preferably 1 to 40 carbon atoms. Specifically, it may be a compound having the following structure, but is not limited thereto.
Figure PCTKR2022010379-appb-img-000005
Figure PCTKR2022010379-appb-img-000005
본 명세서에 있어서, 에스테르기는 에스테르기의 산소가 탄소수 1 내지 25의 직쇄, 분지쇄 또는 고리쇄 알킬기 또는 탄소수 6 내지 25의 아릴기로 치환될 수 있다. 구체적으로, 하기 구조식의 화합물이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the ester group may be substituted with an aryl group having 6 to 25 carbon atoms or a straight-chain, branched-chain or cyclic chain alkyl group having 1 to 25 carbon atoms in the ester group. Specifically, it may be a compound of the following structural formula, but is not limited thereto.
Figure PCTKR2022010379-appb-img-000006
Figure PCTKR2022010379-appb-img-000006
본 명세서에 있어서, 이미드기의 탄소수는 특별히 한정되지 않으나, 탄소수 1 내지 25인 것이 바람직하다. 구체적으로 하기와 같은 구조의 화합물이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the number of carbon atoms of the imide group is not particularly limited, but is preferably 1 to 25 carbon atoms. Specifically, it may be a compound having the following structure, but is not limited thereto.
Figure PCTKR2022010379-appb-img-000007
Figure PCTKR2022010379-appb-img-000007
본 명세서에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다. In the present specification, the silyl group is specifically a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, a phenylsilyl group, and the like. but not limited to
본 명세서에 있어서, 붕소기는 구체적으로 트리메틸붕소기, 트리에틸붕소기, t-부틸디메틸붕소기, 트리페닐붕소기, 페닐붕소기 등이 있으나 이에 한정되지 않는다.In the present specification, the boron group specifically includes a trimethyl boron group, a triethyl boron group, a t-butyldimethyl boron group, a triphenyl boron group, a phenyl boron group, but is not limited thereto.
본 명세서에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In this specification, examples of the halogen group include fluorine, chlorine, bromine or iodine.
본 명세서에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 40인 것이 바람직하다. 일 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알킬기의 탄소수는 1 내지 6이다. 알킬기의 구체적인 예로는 메틸, 에틸, 프로필, n-프로필, 이소프로필, 부틸, n-부틸, 이소부틸, tert-부틸, sec-부틸, 1-메틸-부틸, 1-에틸-부틸, 펜틸, n-펜틸, 이소펜틸, 네오펜틸, tert-펜틸, 헥실, n-헥실, 1-메틸펜틸, 2-메틸펜틸, 4-메틸-2-펜틸, 3,3-디메틸부틸, 2-에틸부틸, 헵틸, n-헵틸, 1-메틸헥실, 사이클로펜틸메틸, 사이클로헥틸메틸, 옥틸, n-옥틸, tert-옥틸, 1-메틸헵틸, 2-에틸헥실, 2-프로필펜틸, n-노닐, 2,2-디메틸헵틸, 1-에틸-프로필, 1,1-디메틸-프로필, 이소헥실, 2-메틸펜틸, 4-메틸헥실, 5-메틸헥실 등이 있으나, 이들에 한정되지 않는다.In the present specification, the alkyl group may be straight-chain or branched-chain, and the number of carbon atoms is not particularly limited, but is preferably 1 to 40. According to one embodiment, the number of carbon atoms of the alkyl group is 1 to 20. According to another exemplary embodiment, the number of carbon atoms of the alkyl group is 1 to 10. According to another exemplary embodiment, the alkyl group has 1 to 6 carbon atoms. Specific examples of the alkyl group include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, tert-butyl, sec-butyl, 1-methyl-butyl, 1-ethyl-butyl, pentyl, n -pentyl, isopentyl, neopentyl, tert-pentyl, hexyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 4-methyl-2-pentyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl , n-heptyl, 1-methylhexyl, cyclopentylmethyl, cyclohexylmethyl, octyl, n-octyl, tert-octyl, 1-methylheptyl, 2-ethylhexyl, 2-propylpentyl, n-nonyl, 2,2 -Dimethylheptyl, 1-ethyl-propyl, 1,1-dimethyl-propyl, isohexyl, 2-methylpentyl, 4-methylhexyl, 5-methylhexyl, etc., but is not limited thereto.
본 명세서에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 일 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 20이다. 또 하나의 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 10이다. 또 하나의 실시상태에 따르면, 상기 알케닐기의 탄소수는 2 내지 6이다. 구체적인 예로는 비닐, 1-프로페닐, 이소프로페닐, 1-부테닐, 2-부테닐, 3-부테닐, 1-펜테닐, 2-펜테닐, 3-펜테닐, 3-메틸-1-부테닐, 1,3-부타디에닐, 알릴, 1-페닐비닐-1-일, 2-페닐비닐-1-일, 2,2-디페닐비닐-1-일, 2-페닐-2-(나프틸-1-일)비닐-1-일, 2,2-비스(디페닐-1-일)비닐-1-일, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present specification, the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. According to one embodiment, the alkenyl group has 2 to 20 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 10 carbon atoms. According to another exemplary embodiment, the alkenyl group has 2 to 6 carbon atoms. Specific examples include vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 3-methyl-1- Butenyl, 1,3-butadienyl, allyl, 1-phenylvinyl-1-yl, 2-phenylvinyl-1-yl, 2,2-diphenylvinyl-1-yl, 2-phenyl-2-( naphthyl-1-yl)vinyl-1-yl, 2,2-bis(diphenyl-1-yl)vinyl-1-yl, stilbenyl group, styrenyl group, etc., but is not limited thereto.
본 명세서에 있어서, 사이클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 일 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 30이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 20이다. 또 하나의 실시상태에 따르면, 상기 사이클로알킬기의 탄소수는 3 내지 6이다. 구체적으로 사이클로프로필, 사이클로부틸, 사이클로펜틸, 3-메틸사이클로펜틸, 2,3-디메틸사이클로펜틸, 사이클로헥실, 3-메틸사이클로헥실, 4-메틸사이클로헥실, 2,3-디메틸사이클로헥실, 3,4,5-트리메틸사이클로헥실, 4-tert-부틸사이클로헥실, 사이클로헵틸, 사이클로옥틸 등이 있으나, 이에 한정되지 않는다.In the present specification, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and according to an exemplary embodiment, the cycloalkyl group has 3 to 30 carbon atoms. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 20. According to another exemplary embodiment, the number of carbon atoms of the cycloalkyl group is 3 to 6. Specifically, cyclopropyl, cyclobutyl, cyclopentyl, 3-methylcyclopentyl, 2,3-dimethylcyclopentyl, cyclohexyl, 3-methylcyclohexyl, 4-methylcyclohexyl, 2,3-dimethylcyclohexyl, 3, 4,5-trimethylcyclohexyl, 4-tert-butylcyclohexyl, cycloheptyl, cyclooctyl, and the like, but are not limited thereto.
본 명세서에 있어서, 아릴기는 특별히 한정되지 않으나 탄소수 6 내지 60인 것이 바람직하며, 단환식 아릴기 또는 다환식 아릴기일 수 있다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 30이다. 일 실시상태에 따르면, 상기 아릴기의 탄소수는 6 내지 20이다. 상기 아릴기가 단환식 아릴기로는 페닐기, 비페닐이기, 터페닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다. 상기 다환식 아릴기로는 나프틸기, 안트라세닐기, 페난쓰레닐기, 파이레닐기, 페릴레닐기, 크라이세닐기, 플루오레닐기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present specification, the aryl group is not particularly limited, but preferably has 6 to 60 carbon atoms, and may be a monocyclic aryl group or a polycyclic aryl group. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 30. According to one embodiment, the number of carbon atoms of the aryl group is 6 to 20. The aryl group may be a phenyl group, a biphenyl group, a terphenyl group, etc. as a monocyclic aryl group, but is not limited thereto. The polycyclic aryl group may be a naphthyl group, anthracenyl group, phenanthrenyl group, pyrenyl group, perylenyl group, chrysenyl group, fluorenyl group, etc., but is not limited thereto.
본 명세서에 있어서, 플루오레닐기는 치환될 수 있고, 치환기 2개가 서로 결합하여 스피로 구조를 형성할 수 있다. 상기 플루오레닐기가 치환되는 경우,
Figure PCTKR2022010379-appb-img-000008
등이 될 수 있다. 다만, 이에 한정되는 것은 아니다.In the present specification, the fluorenyl group may be substituted, and two substituents may be bonded to each other to form a spiro structure. When the fluorenyl group is substituted,
Figure PCTKR2022010379-appb-img-000008
etc. However, it is not limited thereto.
본 명세서에 있어서, 헤테로아릴은 이종 원소로 O, N, Si 및 S 중 1개 이상을 포함하는 헤테로아릴로서, 탄소수는 특별히 한정되지 않으나, 탄소수 2 내지 60인 것이 바람직하다. 헤테로아릴의 예로는 잔텐(xanthene), 티오잔텐(thioxanthen), 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤즈옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 페난쓰롤린기(phenanthroline), 이소옥사졸릴기, 티아디아졸릴기, 페노티아지닐기 및 디벤조퓨라닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present specification, heteroaryl is a heteroaryl containing at least one of O, N, Si, and S as a heterogeneous element, and the number of carbon atoms is not particularly limited, but preferably has 2 to 60 carbon atoms. Examples of the heteroaryl include xanthene, thioxanthen, thiophene, furan, pyrrole, imidazole, thiazole, oxazole, oxadiazole, triazole, pyridyl, bipyridyl, Pyrimidyl group, triazine group, acridyl group, pyridazine group, pyrazinyl group, quinolinyl group, quinazoline group, quinoxalinyl group, phthalazinyl group, pyridopyrimidinyl group, pyridopyrazinyl group, pyrazino Pyrazinyl group, isoquinoline group, indole group, carbazole group, benzoxazole group, benzoimidazole group, benzothiazole group, benzocarbazole group, benzothiophene group, dibenzothiophene group, benzofuranyl group, phenanthroline group ( phenanthroline), an isoxazolyl group, a thiadiazolyl group, a phenothiazinyl group, and a dibenzofuranyl group, but are not limited thereto.
본 명세서에 있어서, 아르알킬기, 아르알케닐기, 알킬아릴기, 아릴아민기, 아릴실릴기 중의 아릴기는 전술한 아릴기의 예시와 같다. 본 명세서에 있어서, 아르알킬기, 알킬아릴기, 알킬아민기 중 알킬기는 전술한 알킬기의 예시와 같다. 본 명세서에 있어서, 헤테로아릴아민 중 헤테로아릴은 전술한 헤테로아릴에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 아르알케닐기 중 알케닐기는 전술한 알케닐기의 예시와 같다. 본 명세서에 있어서, 아릴렌은 2가기인 것을 제외하고는 전술한 아릴기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 헤테로아릴렌은 2가기인 것을 제외하고는 전술한 헤테로아릴에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 탄화수소 고리는 1가기가 아니고, 2개의 치환기가 결합하여 형성한 것을 제외하고는 전술한 아릴기 또는 사이클로알킬기에 관한 설명이 적용될 수 있다. 본 명세서에 있어서, 헤테로고리는 1가기가 아니고, 2개의 치환기가 결합하여 형성한 것을 제외하고는 전술한 헤테로아릴에 관한 설명이 적용될 수 있다.In the present specification, an aralkyl group, an aralkenyl group, an alkylaryl group, an arylamine group, and an aryl group among arylsilyl groups are the same as the examples of the aryl group described above. In the present specification, the alkyl group among the aralkyl group, the alkylaryl group, and the alkylamine group is the same as the examples of the above-mentioned alkyl group. In the present specification, the description of the above-described heteroaryl may be applied to the heteroaryl among heteroarylamines. In the present specification, the alkenyl group among the aralkenyl groups is the same as the examples of the alkenyl group described above. In the present specification, the description of the aryl group described above may be applied except that the arylene is a divalent group. In the present specification, the description of heteroaryl described above may be applied except that the heteroarylene is a divalent group. In the present specification, the hydrocarbon ring is not a monovalent group, and the description of the aryl group or cycloalkyl group described above may be applied, except that the hydrocarbon ring is formed by combining two substituents. In the present specification, the heterocyclic group is not a monovalent group, and the description of the above-described heteroaryl may be applied, except that it is formed by combining two substituents.
(화합물)(compound)
본 발명은 상기 화학식 1로 표시되는 화합물을 제공한다. The present invention provides a compound represented by Formula 1 above.
상기 화학식 1에서 Ar1은 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된 C5-60 헤테로아릴이다. 바람직하게는, Ar1은 페닐; 비페닐릴; 터페닐릴; 나프틸; 페난트렌; (페닐)나프틸; (나프틸)페닐;9,9-디메틸플루오레닐; 9,9-디페닐플루오레닐; 9,9’-스피로비[9H-플루오렌]일; 디벤조퓨라닐; 디벤조싸이오페닐; 9-페닐-카바졸일; 또는 9-나프틸-카르바졸일일 수 있다.In Formula 1, Ar 1 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl. Preferably, Ar 1 is phenyl; biphenylyl; terphenylyl; naphthyl; phenanthrene; (phenyl) naphthyl; (naphthyl)phenyl; 9,9-dimethylfluorenyl; 9,9-diphenylfluorenyl; 9,9'-spirobi[9H-fluorene]yl;dibenzofuranyl;dibenzothiophenyl;9-phenyl-carbazolyl; or 9-naphthyl-carbazolyl.
상기 Ar2는 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된 C5-60 헤테로아릴이다. 바람직하게는, Ar2은 페닐; 비페닐릴; 터페닐릴; 나프틸; 페난트렌; (페닐)나프틸; (나프틸)페닐; 9,9-디메틸플루오레닐; 9,9-디페닐플루오레닐; 9,9’-스피로비[9H-플루오렌]일; 디벤조퓨라닐; 디벤조싸이오페닐; 9-페닐-카바졸일; 또는 9-나프틸-카르바졸일일 수 있다. Ar 2 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl. Preferably, Ar 2 is phenyl; biphenylyl; terphenylyl; naphthyl; phenanthrene; (phenyl) naphthyl; (naphthyl)phenyl; 9,9-dimethylfluorenyl; 9,9-diphenylfluorenyl; 9,9'-spirobi[9H-fluorene]yl;dibenzofuranyl;dibenzothiophenyl;9-phenyl-carbazolyl; or 9-naphthyl-carbazolyl.
L1은 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이다. 바람직하게는, L1은 직접 결합; 또는 페닐렌이다. L 1 is a direct bond; Substituted or unsubstituted C 6-60 arylene; Or a substituted or unsubstituted C 5-60 heteroarylene. Preferably, L 1 is a direct bond; or phenylene.
L2는 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이다. 바람직하게는, L2은 직접 결합; 페닐렌; 터페닐릴렌; 비페닐릴렌; 9,9-디메틸플루오레닐렌; 9,9-디페닐플루오레닐렌; 또는 나프틸렌이다.L 2 is a direct bond; Substituted or unsubstituted C 6-60 arylene; Or a substituted or unsubstituted C 5-60 heteroarylene. Preferably, L 2 is a direct bond; phenylene; terphenylylene; biphenylylene; 9,9-dimethylfluorenylene; 9,9-diphenylfluorenylene; or naphthylene.
L3은 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이다. 바람직하게는, L3은 직접 결합; 페닐렌; 터페닐릴렌; 비페닐릴렌; 9,9-디메틸플루오레닐렌; 9,9-디페닐플루오레닐렌; 또는 나프틸렌이다. L 3 is a direct bond; Substituted or unsubstituted C 6-60 arylene; Or a substituted or unsubstituted C 5-60 heteroarylene. Preferably, L 3 is a direct bond; phenylene; terphenylylene; biphenylylene; 9,9-dimethylfluorenylene; 9,9-diphenylfluorenylene; or naphthylene.
또한 상기 화합물은 화학식 1에서 X1 내지 X4 중 하나에 화학식 2로 표시되는 CR1이 부착되는 것일 수 있다.Also, in the compound, CR 1 represented by Formula 2 may be attached to one of X 1 to X 4 in Formula 1.
상기 화학식 1로 표시되는 화합물의 대표적인 예는 하기와 같다:Representative examples of the compound represented by Formula 1 are as follows:
Figure PCTKR2022010379-appb-img-000009
Figure PCTKR2022010379-appb-img-000009
Figure PCTKR2022010379-appb-img-000010
Figure PCTKR2022010379-appb-img-000010
Figure PCTKR2022010379-appb-img-000011
Figure PCTKR2022010379-appb-img-000011
Figure PCTKR2022010379-appb-img-000012
Figure PCTKR2022010379-appb-img-000012
Figure PCTKR2022010379-appb-img-000013
Figure PCTKR2022010379-appb-img-000013
Figure PCTKR2022010379-appb-img-000014
Figure PCTKR2022010379-appb-img-000014
Figure PCTKR2022010379-appb-img-000015
Figure PCTKR2022010379-appb-img-000015
Figure PCTKR2022010379-appb-img-000016
Figure PCTKR2022010379-appb-img-000016
Figure PCTKR2022010379-appb-img-000017
Figure PCTKR2022010379-appb-img-000017
Figure PCTKR2022010379-appb-img-000018
Figure PCTKR2022010379-appb-img-000018
Figure PCTKR2022010379-appb-img-000019
Figure PCTKR2022010379-appb-img-000019
Figure PCTKR2022010379-appb-img-000020
Figure PCTKR2022010379-appb-img-000020
Figure PCTKR2022010379-appb-img-000021
Figure PCTKR2022010379-appb-img-000021
Figure PCTKR2022010379-appb-img-000022
Figure PCTKR2022010379-appb-img-000022
Figure PCTKR2022010379-appb-img-000023
Figure PCTKR2022010379-appb-img-000023
Figure PCTKR2022010379-appb-img-000024
Figure PCTKR2022010379-appb-img-000024
Figure PCTKR2022010379-appb-img-000025
Figure PCTKR2022010379-appb-img-000025
Figure PCTKR2022010379-appb-img-000026
Figure PCTKR2022010379-appb-img-000026
Figure PCTKR2022010379-appb-img-000027
Figure PCTKR2022010379-appb-img-000027
Figure PCTKR2022010379-appb-img-000028
Figure PCTKR2022010379-appb-img-000028
Figure PCTKR2022010379-appb-img-000029
Figure PCTKR2022010379-appb-img-000029
Figure PCTKR2022010379-appb-img-000030
Figure PCTKR2022010379-appb-img-000030
Figure PCTKR2022010379-appb-img-000031
Figure PCTKR2022010379-appb-img-000031
Figure PCTKR2022010379-appb-img-000032
Figure PCTKR2022010379-appb-img-000032
Figure PCTKR2022010379-appb-img-000033
Figure PCTKR2022010379-appb-img-000033
Figure PCTKR2022010379-appb-img-000034
Figure PCTKR2022010379-appb-img-000034
Figure PCTKR2022010379-appb-img-000035
Figure PCTKR2022010379-appb-img-000035
Figure PCTKR2022010379-appb-img-000036
Figure PCTKR2022010379-appb-img-000036
Figure PCTKR2022010379-appb-img-000037
Figure PCTKR2022010379-appb-img-000037
Figure PCTKR2022010379-appb-img-000038
Figure PCTKR2022010379-appb-img-000038
Figure PCTKR2022010379-appb-img-000039
Figure PCTKR2022010379-appb-img-000039
Figure PCTKR2022010379-appb-img-000040
Figure PCTKR2022010379-appb-img-000040
Figure PCTKR2022010379-appb-img-000041
Figure PCTKR2022010379-appb-img-000041
Figure PCTKR2022010379-appb-img-000042
Figure PCTKR2022010379-appb-img-000042
또한 본 발명은 하기 반응식 1과 같은 상기 화학식 1로 표시되는 화합물의 제조방법을 제공한다.In addition, the present invention provides a method for preparing the compound represented by Formula 1 as shown in Reaction Scheme 1 below.
[반응식 1][Scheme 1]
Figure PCTKR2022010379-appb-img-000043
Figure PCTKR2022010379-appb-img-000043
상기 반응식 1에서 X1 내지 X10, L1, L2, L3, Ar1, 및 Ar2의 정의는 화학식 1 및 화학식 2의 정의와 같다. 또한 반응식 1에서 Y는 할로겐이고, 바람직하게는 클로로이다. In Reaction Scheme 1, X 1 to X 10 , L 1 , L 2 , L 3 , Ar 1 , and Ar 2 are defined as in Formulas 1 and 2. In Scheme 1, Y is halogen, preferably chloro.
상기 반응식 1은 팔라듐 촉매와 염기의 존재하에 수행하는 것이 바람직하고, 상기 제조 방법은 후술할 합성예에서 보다 구체화될 수 있다. Reaction Scheme 1 is preferably carried out in the presence of a palladium catalyst and a base, and the preparation method may be more specific in a synthesis example to be described later.
(유기 발광 소자) (organic light emitting device)
또한, 본 발명은 상기 화학식 1로 표시되는 화합물을 포함하는 유기 발광 소자를 제공한다. 일례로, 본 발명은 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 1층 이상의 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층 중 1층 이상은 상기 화학식 1로 표시되는 화합물을 포함하는, 유기 발광 소자를 제공한다.In addition, the present invention provides an organic light emitting device including the compound represented by Formula 1 above. In one example, the present invention provides a first electrode; a second electrode provided to face the first electrode; and one or more organic material layers provided between the first electrode and the second electrode, wherein at least one of the organic material layers includes the compound represented by Chemical Formula 1. .
본 발명의 유기 발광 소자의 유기물 층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 본 발명의 유기 발광 소자는 유기물 층으로서 정공주입층, 정공수송층, 발광층, 정공저지층, 전자수송층, 전자주입층 등을 포함하는 구조를 가질 수 있다. 그러나 유기 발광 소자의 구조는 이에 한정되지 않고 더 적은 수의 유기층을 포함할 수 있다.The organic material layer of the organic light emitting device of the present invention may have a single-layer structure, or may have a multi-layer structure in which two or more organic material layers are stacked. For example, the organic light emitting device of the present invention may have a structure including a hole injection layer, a hole transport layer, a light emitting layer, a hole blocking layer, an electron transport layer, an electron injection layer, and the like as organic layers. However, the structure of the organic light emitting device is not limited thereto and may include fewer organic layers.
또한, 상기 유기물 층은 정공주입층, 정공수송층, 또는 정공 주입과 수송을 동시에 하는 층을 포함할 수 있고, 상기 정공주입층, 정공수송층, 또는 정공 주입과 수송을 동시에 하는 층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.In addition, the organic material layer may include a hole injection layer, a hole transport layer, or a layer that simultaneously injects and transports holes, and the hole injection layer, the hole transport layer, or a layer that simultaneously injects and transports holes is represented by Formula 1 above. may contain the indicated compounds.
또한, 상기 유기물 층은 발광층을 포함할 수 있고, 상기 발광층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. Also, the organic material layer may include a light emitting layer, and the light emitting layer may include the compound represented by Chemical Formula 1.
또한, 상기 유기물 층은 정공저지층, 전자수송층, 전자주입층, 또는 전자수송 및 전자주입을 동시에 하는 층을 포함할 수 있고, 상기 정공저지층, 전자수송층, 전자주입층, 또는 전자수송 및 전자주입을 동시에 하는 층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. In addition, the organic material layer may include a hole blocking layer, an electron transport layer, an electron injection layer, or a layer that simultaneously transports and injects electrons, and the hole blocking layer, the electron transport layer, the electron injection layer, or the electron transport and electron injection layer. The layer to be simultaneously injected may include the compound represented by Chemical Formula 1 above.
또한, 상기 유기물 층은 발광층 및 전자 주입 및 수송층을 포함할 수 있고, 상기 전자 주입 및 수송층은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.Also, the organic material layer may include a light emitting layer and an electron injection and transport layer, and the electron injection and transport layer may include the compound represented by Chemical Formula 1.
또한, 본 발명에 따른 유기 발광 소자는, 기판 상에 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층된 구조(normal type)의 유기 발광 소자일 수 있다. 또한, 본 발명에 따른 유기 발광 소자는 기판 상에 음극, 1층 이상의 유기물층 및 양극이 순차적으로 적층된 역방향 구조(inverted type)의 유기 발광 소자일 수 있다. 예컨대, 본 발명의 일실시예에 따른 유기 발광 소자의 구조는 도 1 및 2에 예시되어 있다.Also, the organic light emitting device according to the present invention may be a normal type organic light emitting device in which an anode, one or more organic material layers, and a cathode are sequentially stacked on a substrate. In addition, the organic light emitting device according to the present invention may be an organic light emitting device of an inverted type in which a cathode, one or more organic material layers, and an anode are sequentially stacked on a substrate. For example, the structure of an organic light emitting device according to an embodiment of the present invention is illustrated in FIGS. 1 and 2 .
도 1은 기판(1), 양극(2), 발광층(3), 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다. 1 shows an example of an organic light emitting device composed of a substrate 1, an anode 2, a light emitting layer 3, and a cathode 4.
도 2는 기판 (1), 양극(2), 정공주입층(5), 정공수송층(6), 발광층(7), 전자 주입 및 수송층(8) 및 음극(4)으로 이루어진 유기 발광 소자의 예를 도시한 것이다. 이와 같은 구조에 있어서, 상기 화학식 1로 표시되는 화합물은 상기 발광층에 포함될 수 있다.2 is an example of an organic light emitting device composed of a substrate (1), an anode (2), a hole injection layer (5), a hole transport layer (6), a light emitting layer (7), an electron injection and transport layer (8) and a cathode (4). is shown. In this structure, the compound represented by Chemical Formula 1 may be included in the light emitting layer.
본 발명에 따른 유기 발광 소자는, 상기 유기물 층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는 당 기술분야에 알려져 있는 재료와 방법으로 제조될 수 있다. 또한, 상기 유기 발광 소자가 복수개의 유기물층을 포함하는 경우, 상기 유기물층은 동일한 물질 또는 다른 물질로 형성될 수 있다.The organic light emitting device according to the present invention may be manufactured using materials and methods known in the art, except that at least one of the organic layers includes the compound represented by Chemical Formula 1. Also, when the organic light emitting device includes a plurality of organic material layers, the organic material layers may be formed of the same material or different materials.
예컨대, 본 발명에 따른 유기 발광 소자는 기판 상에 양극, 유기물층 및 음극을 순차적으로 적층시켜 제조할 수 있다. 이때, 스퍼터링법(sputtering)이나 전자빔 증발법(e-beam evaporation)과 같은 PVD(physical Vapor Deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층 및 전자 수송층을 포함하는 유기물 층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시켜 제조할 수 있다. 이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 만들 수 있다.For example, the organic light emitting device according to the present invention may be manufactured by sequentially stacking an anode, an organic material layer, and a cathode on a substrate. At this time, using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation, depositing a metal or a metal oxide having conductivity or an alloy thereof on the substrate to form an anode After forming an organic material layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer thereon, and depositing a material that can be used as a cathode thereon, it can be prepared. In addition to this method, an organic light emitting device may be manufactured by sequentially depositing a cathode material, an organic material layer, and an anode material on a substrate.
또한, 상기 화학식 1로 표시되는 화합물은 유기 발광 소자의 제조시 진공 증착법 뿐만 아니라 용액 도포법에 의하여 유기물 층으로 형성될 수 있다. 여기서, 용액 도포법이라 함은 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅, 스크린 프린팅, 스프레이법, 롤 코팅 등을 의미하지만, 이들만으로 한정되는 것은 아니다.In addition, the compound represented by Chemical Formula 1 may be formed as an organic material layer by a solution coating method as well as a vacuum deposition method when manufacturing an organic light emitting device. Here, the solution coating method means spin coating, dip coating, doctor blading, inkjet printing, screen printing, spraying, roll coating, etc., but is not limited to these.
이와 같은 방법 외에도, 기판 상에 음극 물질로부터 유기물층, 양극 물질을 차례로 증착시켜 유기 발광 소자를 제조할 수 있다(WO 2003/012890). 다만, 제조 방법이 이에 한정되는 것은 아니다. In addition to this method, an organic light emitting device may be manufactured by sequentially depositing an organic material layer and an anode material on a substrate from a cathode material (WO 2003/012890). However, the manufacturing method is not limited thereto.
일례로, 상기 제1 전극은 양극이고, 상기 제2 전극은 음극이거나, 또는 상기 제1 전극은 음극이고, 상기 제2 전극은 양극이다.In one example, the first electrode is an anode and the second electrode is a cathode, or the first electrode is a cathode and the second electrode is an anode.
상기 양극 물질로는 통상 유기물층으로 정공 주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 상기 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연 산화물, 인듐 산화물, 인듐주석 산화물(ITO), 인듐아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDOT), 폴리피롤 및 폴리아닐린과 같은 전도성 화합물 등이 있으나, 이들에만 한정되는 것은 아니다. As the anode material, a material having a high work function is generally preferred so that holes can be smoothly injected into the organic material layer. Specific examples of the cathode material include metals such as vanadium, chromium, copper, zinc, and gold or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; conductive compounds such as poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDOT), polypyrrole, and polyaniline; and the like, but are not limited thereto.
상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 상기 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 티타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다. The cathode material is preferably a material having a small work function so as to easily inject electrons into the organic material layer. Specific examples of the anode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, and lead, or alloys thereof; There are multi-layered materials such as LiF/Al or LiO 2 /Al, but are not limited thereto.
상기 정공주입층은 전극으로부터 정공을 주입하는 층으로, 정공 주입 물질로는 정공을 수송하는 능력을 가져 양극에서의 정공 주입효과, 발광층 또는 발광재료에 대하여 우수한 정공 주입 효과를 갖고, 발광층에서 생성된 여기자의 전자주입층 또는 전자주입재료에의 이동을 방지하며, 또한, 박막 형성 능력이 우수한 화합물이 바람직하다. 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물 층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrin), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴헥사아자트리페닐렌 계열의 유기물, 퀴나크리돈(quinacridone)계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 화합물 등이 있으나, 이들에만 한정 되는 것은 아니다. The hole injection layer is a layer for injecting holes from the electrode, and the hole injection material has the ability to transport holes and has a hole injection effect at the anode, an excellent hole injection effect for the light emitting layer or the light emitting material, and generated in the light emitting layer A compound that prevents migration of excitons to the electron injecting layer or electron injecting material and has excellent thin film formation ability is preferred. It is preferable that the highest occupied molecular orbital (HOMO) of the hole injection material is between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injection material include metal porphyrins, oligothiophenes, arylamine-based organic materials, hexanitrilehexaazatriphenylene-based organic materials, quinacridone-based organic materials, and perylene-based organic materials. of organic matter, anthraquinone, and polyaniline and polythiophene-based conductive compounds, but are not limited thereto.
상기 정공수송층은 정공주입층으로부터 정공을 수취하여 발광층까지 정공을 수송하는 층으로, 정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 화합물, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다. The hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light emitting layer. The hole transport material is a material that can receive holes from the anode or the hole injection layer and transfer them to the light emitting layer, and has high hole mobility. material is suitable. Specific examples include, but are not limited to, arylamine-based organic materials, conductive compounds, and block copolymers having both conjugated and non-conjugated parts.
상기 발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자 효율이 좋은 물질이 바람직하다. 구체적인 예로 8-히드록시-퀴놀린 알루미늄 착물(Alq3); 카르바졸 계열 화합물; 이량체화 스티릴(dimerized styryl) 화합물; BAlq; 10-히드록시벤조 퀴놀린-금속 화합물; 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물; 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자; 스피로(spiro) 화합물; 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The light emitting material is a material capable of emitting light in the visible ray region by receiving and combining holes and electrons from the hole transport layer and the electron transport layer, respectively, and a material having good quantum efficiency for fluorescence or phosphorescence is preferable. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ); carbazole-based compounds; dimerized styryl compounds; BAlq; 10-hydroxybenzoquinoline-metal compounds; compounds of the benzoxazole, benzthiazole and benzimidazole series; poly(p-phenylenevinylene) (PPV)-based polymers; spiro compounds; Polyfluorene, rubrene, etc., but are not limited thereto.
상기 전자억제층은 음극에서 주입된 전자가 발광층에서 재결합되지 않고 정공수송층으로 넘어가는 것을 방지하기 위해 정공수송층과 발광층의 사이에 두는 층으로, 전자저지층으로 불리기도 한다. 전자억제층에는 전자수송층보다 전자 친화력이 작은 물질이 바람직하다. 바람직하게는, 상기 화학식 1로 표시되는 화합물을 전자억제층의 물질로 포함할 수 있다.The electron blocking layer is a layer placed between the hole transport layer and the light emitting layer to prevent electrons injected from the cathode from passing to the hole transport layer without recombination in the light emitting layer, and is also called an electron blocking layer. A material having a smaller electron affinity than the electron transport layer is preferable for the electron blocking layer. Preferably, the compound represented by Chemical Formula 1 may be included as a material of the electron blocking layer.
상기 발광층은 호스트 재료 및 도펀트 재료를 포함할 수 있다. 호스트 재료로는 상술한 화학식 1로 표시되는 화합물이 사용될 수 있다. 또한, 추가로 사용할 수 있는 호스트 재료로는 축합 방향족환 유도체 또는 헤테로환 함유 화합물 등을 사용할 수 있다. 구체적으로 축합 방향족환 유도체로는 안트라센 유도체, 피렌 유도체, 나프탈렌 유도체, 펜타센 유도체, 페난트렌 화합물, 플루오란텐 화합물 등이 있고, 헤테로환 함유 화합물로는 카바졸 유도체, 디벤조퓨란 유도체, 래더형 퓨란 화합물, 피리미딘 유도체 등이 있으나, 이에 한정되지 않는다. The light emitting layer may include a host material and a dopant material. As the host material, the compound represented by Chemical Formula 1 may be used. In addition, as a host material that can be further used, a condensed aromatic ring derivative or a compound containing a heterocyclic ring can be used. Specifically, condensed aromatic ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, etc., and heterocyclic-containing compounds include carbazole derivatives, dibenzofuran derivatives, ladder type furan compounds, pyrimidine derivatives, etc., but are not limited thereto.
도펀트 재료로는 방향족 아민 유도체, 스트릴아민 화합물, 붕소 착체, 플루오란텐 화합물, 금속 착체 등이 있다. 구체적으로 방향족 아민 유도체로는 치환 또는 비치환된 아릴아미노기를 갖는 축합 방향족환 유도체로서, 아릴아미노기를 갖는 피렌, 안트라센, 크리센, 페리플란텐 등이 있으며, 스티릴아민 화합물로는 치환 또는 비치환된 아릴아민에 적어도 1개의 아릴비닐기가 치환되어 있는 화합물로, 아릴기, 실릴기, 알킬기, 사이클로알킬기 및 아릴아미노기로 이루어진 군에서 1 또는 2 이상 선택되는 치환기가 치환 또는 비치환된다. 구체적으로 스티릴아민, 스티릴디아민, 스티릴트리아민, 스티릴테트라아민 등이 있으나, 이에 한정되지 않는다. 또한, 금속 착체로는 이리듐 착체, 백금 착체 등이 있으나, 이에 한정되지 않는다.Dopant materials include aromatic amine derivatives, strylamine compounds, boron complexes, fluoranthene compounds, metal complexes, and the like. Specifically, aromatic amine derivatives are condensed aromatic ring derivatives having a substituted or unsubstituted arylamino group, such as pyrene, anthracene, chrysene, periplanthene, etc. having an arylamino group, and styrylamine compounds include substituted or unsubstituted arylamine is substituted with at least one arylvinyl group, wherein one or two or more substituents selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group, and an arylamino group are substituted or unsubstituted. Specifically, there are styrylamine, styryldiamine, styryltriamine, styryltetraamine, etc., but is not limited thereto. In addition, metal complexes include, but are not limited to, iridium complexes and platinum complexes.
예컨대, 본 발명의 도펀트 재료로는 하기 Dp-1 내지 Dp-38 중 하나를 들 수 있으며, 이에 한하는 것은 아니다.For example, as the dopant material of the present invention, one of the following Dp-1 to Dp-38 may be mentioned, but is not limited thereto.
Figure PCTKR2022010379-appb-img-000044
Figure PCTKR2022010379-appb-img-000044
Figure PCTKR2022010379-appb-img-000045
Figure PCTKR2022010379-appb-img-000045
Figure PCTKR2022010379-appb-img-000046
Figure PCTKR2022010379-appb-img-000046
Figure PCTKR2022010379-appb-img-000047
Figure PCTKR2022010379-appb-img-000047
상기 전자수송층은 전자주입층으로부터 전자를 수취하여 발광층까지 전자를 수송하는 층으로 전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물; Alq3를 포함한 착물; 유기 라디칼 화합물; 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다. 전자 수송층은 종래기술에 따라 사용된 바와 같이 임의의 원하는 캐소드 물질과 함께 사용할 수 있다. 특히, 적절한 캐소드 물질의 예는 낮은 일함수를 가지고 알루미늄층 또는 실버층이 뒤따르는 통상적인 물질이다. 구체적으로 세슘, 바륨, 칼슘, 이테르븀 및 사마륨이고, 각 경우 알루미늄 층 또는 실버층이 뒤따른다.The electron transport layer is a layer that receives electrons from the electron injection layer and transports electrons to the light emitting layer. As the electron transport material, a material capable of receiving electrons from the cathode and transferring them to the light emitting layer is suitable. Do. Specific examples include Al complexes of 8-hydroxyquinoline; Complexes containing Alq 3 ; organic radical compounds; hydroxyflavone-metal complexes and the like, but are not limited thereto. The electron transport layer can be used with any desired cathode material as used according to the prior art. In particular, examples of suitable cathode materials are conventional materials having a low work function followed by a layer of aluminum or silver. Specifically cesium, barium, calcium, ytterbium and samarium, followed in each case by a layer of aluminum or silver.
상기 전자주입층은 전극으로부터 전자를 주입하는 층으로, 전자를 수송하는 능력을 갖고, 음극으로부터의 전자 주입 효과, 발광층 또는 발광 재료에 대하여 우수한 전자주입 효과를 가지며, 발광층에서 생성된 여기자의 정공주입층에의 이동을 방지하고, 또한, 박막형성능력이 우수한 화합물이 바람직하다. 구체적으로는 플루오레논, 안트라퀴노다이메탄, 다이페노퀴논, 티오피란 다이옥사이드, 옥사졸, 옥사다이아졸, 트리아졸, 이미다졸, 페릴렌테트라카복실산, 프레오레닐리덴 메탄, 안트론 등과 그들의 유도체, 금속 착체 화합물 및 질소 함유 5원환 유도체 등이 있으나, 이에 한정되지 않는다.The electron injection layer is a layer for injecting electrons from an electrode, has the ability to transport electrons, has an excellent electron injection effect from a cathode, an excellent electron injection effect for a light emitting layer or a light emitting material, and injects holes of excitons generated in the light emitting layer. A compound that prevents migration to a layer and has excellent thin film forming ability is preferred. Specifically, fluorenone, anthraquinodimethane, diphenoquinone, thiopyran dioxide, oxazole, oxadiazole, triazole, imidazole, perylenetetracarboxylic acid, preonylidene methane, anthrone, etc. and their derivatives, metals complex compounds and nitrogen-containing 5-membered ring derivatives, but are not limited thereto.
상기 금속 착체 화합물로서는 8-하이드록시퀴놀리나토 리튬, 비스(8-하이드록시퀴놀리나토)아연, 비스(8-하이드록시퀴놀리나토)구리, 비스(8-하이드록시퀴놀리나토)망간, 트리스(8-하이드록시퀴놀리나토)알루미늄, 트리스(2-메틸-8-하이드록시퀴놀리나토)알루미늄, 트리스(8-하이드록시퀴놀리나토)갈륨, 비스(10-하이드록시벤조[h]퀴놀리나토)베릴륨, 비스(10-하이드록시벤조[h]퀴놀리나토)아연, 비스(2-메틸-8-퀴놀리나토)클로로갈륨, 비스(2-메틸-8-퀴놀리나토)(o-크레졸라토)갈륨, 비스(2-메틸-8-퀴놀리나토)(1-나프톨라토)알루미늄, 비스(2-메틸-8-퀴놀리나토)(2-나프톨라토)갈륨 등이 있으나, 이에 한정되지 않는다.Examples of the metal complex compound include 8-hydroxyquinolinato lithium, bis(8-hydroxyquinolinato)zinc, bis(8-hydroxyquinolinato)copper, bis(8-hydroxyquinolinato)manganese, Tris(8-hydroxyquinolinato) aluminum, tris(2-methyl-8-hydroxyquinolinato) aluminum, tris(8-hydroxyquinolinato) gallium, bis(10-hydroxybenzo[h] Quinolinato) beryllium, bis(10-hydroxybenzo[h]quinolinato)zinc, bis(2-methyl-8-quinolinato)chlorogallium, bis(2-methyl-8-quinolinato)( There are o-cresolato) gallium, bis(2-methyl-8-quinolinato)(1-naphtolato)aluminum, and bis(2-methyl-8-quinolinato)(2-naphtolato)gallium. Not limited to this.
한편, 본 발명에 있어서 "전자 주입 및 수송층"은 상기 전자주입층과 상기 전자수송층의 역할을 모두 수행하는 층으로 상기 각 층의 역할을 하는 물질을 단독으로, 혹은 혼합하여 사용할 수 있으나, 이에 한정되지 않는다. 바람직하게는, 상기 화학식 1로 표시되는 화합물을 전자 주입 및 수송층의 물질로 포함할 수 있다.On the other hand, in the present invention, the "electron injection and transport layer" is a layer that performs both the roles of the electron injection layer and the electron transport layer, and materials that play the role of each layer may be used alone or in combination, but are limited thereto. It doesn't work. Preferably, the compound represented by Formula 1 may be included as a material for the electron injection and transport layer.
본 발명에 따른 유기 발광 소자는 배면 발광(Bottom emission) 소자, 전면 발광(Top emission) 소자, 또는 양면 발광 소자일 수 있으며, 특히 상대적으로 높은 발광 효율이 요구되는 배면 발광 소자일 수 있다.The organic light emitting device according to the present invention may be a bottom emission device, a top emission device, or a double-sided light emitting device, and in particular, may be a bottom emission device requiring relatively high light emitting efficiency.
또한, 본 발명에 따른 화합물은 유기 발광 소자 외에도 유기 태양 전지 또는 유기 트랜지스터에 포함될 수 있다.In addition, the compound according to the present invention may be included in an organic solar cell or an organic transistor in addition to an organic light emitting device.
상기 화학식 1로 표시되는 화합물 및 이를 포함하는 유기 발광 소자의 제조는 이하 실시예에서 구체적으로 설명한다. 그러나 하기 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의하여 한정되는 것은 아니다.Preparation of the compound represented by Chemical Formula 1 and the organic light emitting device including the same will be described in detail in the following examples. However, the following examples are intended to illustrate the present invention, and the scope of the present invention is not limited thereto.
[제조예][Production Example]
제조예 1Preparation Example 1
Figure PCTKR2022010379-appb-img-000048
Figure PCTKR2022010379-appb-img-000048
3-브로모-2-클로로피리딘-4-아민(15 g, 72.3 mmol)와 (1-메톡시나프탈렌-2-일)보론산(15.3 g, 75.9 mmol)을 테트라하이드로퓨란(300 ml)에 넣고 교반 및 환류하였다. 이 후 포타슘 카보네이트(30 g, 216.9 mmol)를 물(90 ml)에 녹여 투입하고 충분히 교반한 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.7 mmol)을 투입하였다. 4시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 A-a-1_P1를 14.6 g 제조하였다. (수율 71%, MS: [M+H]+= 285)3-Bromo-2-chloropyridin-4-amine (15 g, 72.3 mmol) and (1-methoxynaphthalen-2-yl) boronic acid (15.3 g, 75.9 mmol) were dissolved in tetrahydrofuran (300 ml). It was added and stirred and refluxed. Thereafter, potassium carbonate (30 g, 216.9 mmol) was dissolved in water (90 ml), and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.7 mmol) was added. After reacting for 4 hours, the mixture was cooled to room temperature, and the organic layer and the water layer were separated and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 14.6 g of compound Aa-1_P1. (Yield 71%, MS: [M+H] + = 285)
화합물 A-a-1_P1(10 g, 35.1 mmol)와 HBF4(6.2 g, 70.2 mmol)를 아세토니트릴(100 ml)에 넣고 교반하였다. 이 후 NaNO2(4.8 g, 70.2 mmol)를 H2O(20 ml)에 녹여서 0℃에서 천천히 넣어주었다. 10시간 반응 후 이를 실온까지 승온 후, 물(200 ml)를 넣어 희석하였다. 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 A-a-1를 6.6g 제조하였다. (수율 74%, MS: [M+H]+= 254)Compound Aa-1_P1 (10 g, 35.1 mmol) and HBF 4 (6.2 g, 70.2 mmol) were put in acetonitrile (100 ml) and stirred. Thereafter, NaNO 2 (4.8 g, 70.2 mmol) was dissolved in H 2 O (20 ml) and added slowly at 0°C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with water (200 ml). After completely dissolving in chloroform and washing twice with water, the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.6 g of Compound Aa-1. (Yield 74%, MS: [M+H] + = 254)
제조예 2Preparation Example 2
Figure PCTKR2022010379-appb-img-000049
Figure PCTKR2022010379-appb-img-000049
3-브로모-2-클로로피리딘-4-아민대신 5-브로모-2-클로로피리딘-4-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-a-2 를 제조하였다.Compound A-a-2 was prepared in the same manner as in Preparation Example 1, except that 5-bromo-2-chloropyridin-4-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 3Preparation Example 3
Figure PCTKR2022010379-appb-img-000050
Figure PCTKR2022010379-appb-img-000050
3-브로모-2-클로로피리딘-4-아민대신 3-브로모-5-클로로피리딘-4-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-a-3를 제조하였다.Compound A-a-3 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-5-chloropyridin-4-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 4Production Example 4
Figure PCTKR2022010379-appb-img-000051
Figure PCTKR2022010379-appb-img-000051
3-브로모-2-클로로피리딘-4-아민대신 4-브로모-5-클로로피리딘-3-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-b-1를 제조하였다.Compound A-b-1 was prepared in the same manner as in Preparation Example 1, except that 4-bromo-5-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 5Preparation Example 5
Figure PCTKR2022010379-appb-img-000052
Figure PCTKR2022010379-appb-img-000052
3-브로모-2-클로로피리딘-4-아민대신 4-브로모-6-클로로피리딘-3-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-b-2를 제조하였다.Compound A-b-2 was prepared in the same manner as in Preparation Example 1, except that 4-bromo-6-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 6Preparation Example 6
Figure PCTKR2022010379-appb-img-000053
Figure PCTKR2022010379-appb-img-000053
3-브로모-2-클로로피리딘-4-아민대신 4-브로모-2-클로로피리딘-3-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-b-3를 제조하였다.Compound A-b-3 was prepared in the same manner as in Preparation Example 1, except that 4-bromo-2-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 7Preparation Example 7
Figure PCTKR2022010379-appb-img-000054
Figure PCTKR2022010379-appb-img-000054
3-브로모-2-클로로피리딘-4-아민대신 3-브로모-4-클로로피리딘-2-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-c-1를 제조하였다.Compound A-c-1 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-4-chloropyridin-2-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 8Preparation Example 8
Figure PCTKR2022010379-appb-img-000055
Figure PCTKR2022010379-appb-img-000055
3-브로모-2-클로로피리딘-4-아민대신 3-브로모-5-클로로피리딘-2-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-c-2를 제조하였다.Compound A-c-2 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-5-chloropyridin-2-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 9Preparation Example 9
Figure PCTKR2022010379-appb-img-000056
Figure PCTKR2022010379-appb-img-000056
3-브로모-2-클로로피리딘-4-아민대신 3-브로모-6-클로로피리딘-2-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-c-3를 제조하였다.Compound A-c-3 was prepared in the same manner as in Preparation Example 1, except that 3-bromo-6-chloropyridin-2-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 10Preparation Example 10
Figure PCTKR2022010379-appb-img-000057
Figure PCTKR2022010379-appb-img-000057
3-브로모-2-클로로피리딘-4-아민대신 2-브로모-4-클로로피리딘-3-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-d-1를 제조하였다.Compound A-d-1 was prepared in the same manner as in Preparation Example 1, except that 2-bromo-4-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 11Preparation Example 11
Figure PCTKR2022010379-appb-img-000058
Figure PCTKR2022010379-appb-img-000058
3-브로모-2-클로로피리딘-4-아민대신 2-브로모-5-클로로피리딘-3-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-d-2를 제조하였다.Compound A-d-2 was prepared in the same manner as in Preparation Example 1, except that 2-bromo-5-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 12Preparation Example 12
Figure PCTKR2022010379-appb-img-000059
Figure PCTKR2022010379-appb-img-000059
3-브로모-2-클로로피리딘-4-아민대신 2-브로모-6-클로로피리딘-3-아민을 사용한 것을 제외하고는 제조예 1과 같은 방법으로 화합물 A-d-3를 제조하였다.Compound A-d-3 was prepared in the same manner as in Preparation Example 1, except that 2-bromo-6-chloropyridin-3-amine was used instead of 3-bromo-2-chloropyridin-4-amine.
제조예 13Preparation Example 13
Figure PCTKR2022010379-appb-img-000060
Figure PCTKR2022010379-appb-img-000060
7-브로모퀴놀린-8-아민(15 g, 67.2 mmol)과 (2-클로로-6-메톡시페닐)보론산(13.2 g, 70.6 mmol)을 테트라하이드로퓨란(300 ml)에 넣고 교반 및 환류하였다. 이 후 포타슘 카보네이트(27.9 g, 201.7 mmol)를 물(84 ml)에 녹여 투입하고 충분히 교반한 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.3 g, 0.7 mmol)을 투입하였다. 3 시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 B-a-1_P1를 12.6 g 제조하였다. (수율 66%, MS: [M+H]+= 285)7-Bromoquinolin-8-amine (15 g, 67.2 mmol) and (2-chloro-6-methoxyphenyl) boronic acid (13.2 g, 70.6 mmol) were added to tetrahydrofuran (300 ml), stirred and refluxed. did Thereafter, potassium carbonate (27.9 g, 201.7 mmol) was dissolved in water (84 ml), and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.3 g, 0.7 mmol) was added. After reacting for 3 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 12.6 g of compound Ba-1_P1. (Yield 66%, MS: [M+H] + = 285)
화합물 B-a-1_P1(10 g, 35.1 mmol)와 HBF4 (6.2 g, 70.2 mmol)를 아세토니트릴(100 ml)에 넣고 교반하였다. 이 후 NaNO2(4.8 g, 70.2 mmol)를 H2O(20 ml)에 녹여서 0℃에서 천천히 넣어주었다. 10시간 반응 후 이를 실온까지 승온 후, 물(200ml)를 넣어 희석하였다. 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 B-a-1를 6.1g 제조하였다. (수율 68%, MS: [M+H]+= 254)Compound Ba-1_P1 (10 g, 35.1 mmol) and HBF 4 (6.2 g, 70.2 mmol) were put in acetonitrile (100 ml) and stirred. Thereafter, NaNO 2 (4.8 g, 70.2 mmol) was dissolved in H 2 O (20 ml) and added slowly at 0°C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with water (200ml). After completely dissolving in chloroform and washing twice with water, the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.1 g of compound Ba-1. (Yield 68%, MS: [M+H] + = 254)
제조예 14Preparation Example 14
Figure PCTKR2022010379-appb-img-000061
Figure PCTKR2022010379-appb-img-000061
(2-클로로-6-메톡시페닐)보론산 대신 (5-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-a-2를 제조하였다.Compound B-a-2 was prepared in the same manner as in Preparation Example 13, except that (5-chloro-2-methoxyphenyl)boronic acid was used instead of (2-chloro-6-methoxyphenyl)boronic acid.
제조예 15Preparation Example 15
Figure PCTKR2022010379-appb-img-000062
Figure PCTKR2022010379-appb-img-000062
(2-클로로-6-메톡시페닐)보론산 대신 (4-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-a-3를 제조하였다.Compound B-a-3 was prepared in the same manner as in Preparation Example 13, except that (4-chloro-2-methoxyphenyl)boronic acid was used instead of (2-chloro-6-methoxyphenyl)boronic acid.
제조예 16Preparation Example 16
Figure PCTKR2022010379-appb-img-000063
Figure PCTKR2022010379-appb-img-000063
(2-클로로-6-메톡시페닐)보론산 대신 (3-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-a-4를 제조하였다.Compound B-a-4 was prepared in the same manner as in Preparation Example 13, except that (3-chloro-2-methoxyphenyl)boronic acid was used instead of (2-chloro-6-methoxyphenyl)boronic acid.
제조예 17Preparation Example 17
Figure PCTKR2022010379-appb-img-000064
Figure PCTKR2022010379-appb-img-000064
7-브로모퀴놀린-8-아민대신 7-브로모이소퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-b-1를 제조하였다.Compound B-b-1 was prepared in the same manner as in Preparation Example 13, except that 7-bromoisoquinolin-8-amine was used instead of 7-bromoquinolin-8-amine.
제조예 18Preparation Example 18
Figure PCTKR2022010379-appb-img-000065
Figure PCTKR2022010379-appb-img-000065
7-브로모퀴놀린-8-아민대신 7-브로모이소퀴놀린-8-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (5-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-b-2를 제조하였다.Use 7-bromoisoquinolin-8-amine instead of 7-bromoquinolin-8-amine, and (5-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-b-2 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 19Preparation Example 19
Figure PCTKR2022010379-appb-img-000066
Figure PCTKR2022010379-appb-img-000066
7-브로모퀴놀린-8-아민대신 7-브로모이소퀴놀린-8-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (4-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-b-3를 제조하였다.Use 7-bromoisoquinolin-8-amine instead of 7-bromoquinolin-8-amine, and (4-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-b-3 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 20Production Example 20
Figure PCTKR2022010379-appb-img-000067
Figure PCTKR2022010379-appb-img-000067
7-브로모퀴놀린-8-아민대신 7-브로모이소퀴놀린-8-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (3-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-b-4를 제조하였다.Use 7-bromoisoquinolin-8-amine instead of 7-bromoquinolin-8-amine, and (3-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-b-4 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 21Production Example 21
Figure PCTKR2022010379-appb-img-000068
Figure PCTKR2022010379-appb-img-000068
7-브로모퀴놀린-8-아민대신 6-브로모이소퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-c-1를 제조하였다.Compound B-c-1 was prepared in the same manner as in Preparation Example 13, except that 6-bromoisoquinolin-5-amine was used instead of 7-bromoquinolin-8-amine.
제조예 22Production Example 22
Figure PCTKR2022010379-appb-img-000069
Figure PCTKR2022010379-appb-img-000069
7-브로모퀴놀린-8-아민대신 6-브로모이소퀴놀린-5-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (5-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-c-2를 제조하였다.Use 6-bromoisoquinolin-5-amine instead of 7-bromoquinolin-8-amine, and (5-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-c-2 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 23Production Example 23
Figure PCTKR2022010379-appb-img-000070
Figure PCTKR2022010379-appb-img-000070
7-브로모퀴놀린-8-아민대신 6-브로모이소퀴놀린-5-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (4-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-c-3를 제조하였다.Use 6-bromoisoquinolin-5-amine instead of 7-bromoquinolin-8-amine, and (4-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-c-3 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 24Production Example 24
Figure PCTKR2022010379-appb-img-000071
Figure PCTKR2022010379-appb-img-000071
7-브로모퀴놀린-8-아민대신 6-브로모이소퀴놀린-5-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (3-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-c-4를 제조하였다.Use 6-bromoisoquinolin-5-amine instead of 7-bromoquinolin-8-amine, and (3-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-c-4 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 25Preparation Example 25
Figure PCTKR2022010379-appb-img-000072
Figure PCTKR2022010379-appb-img-000072
7-브로모퀴놀린-8-아민대신 6-브로모퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-d-1를 제조하였다.Compound B-d-1 was prepared in the same manner as in Preparation Example 13, except that 6-bromoquinolin-5-amine was used instead of 7-bromoquinolin-8-amine.
제조예 26Production Example 26
Figure PCTKR2022010379-appb-img-000073
Figure PCTKR2022010379-appb-img-000073
7-브로모퀴놀린-8-아민대신 6-브로모퀴놀린-5-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (5-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-d-2를 제조하였다.Use 6-bromoquinolin-5-amine instead of 7-bromoquinolin-8-amine, (5-chloro-2-methoxyphenyl)boronic acid instead of (2-chloro-6-methoxyphenyl)boronic acid Compound B-d-2 was prepared in the same manner as in Preparation Example 13, except for using.
제조예 27Production Example 27
Figure PCTKR2022010379-appb-img-000074
Figure PCTKR2022010379-appb-img-000074
7-브로모퀴놀린-8-아민대신 6-브로모퀴놀린-5-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (4-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-d-3를 제조하였다.Use 6-bromoquinolin-5-amine instead of 7-bromoquinolin-8-amine, and (4-chloro-2-methoxyphenyl)boronic acid instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-d-3 was prepared in the same manner as in Preparation Example 13, except that was used.
제조예 28Production Example 28
Figure PCTKR2022010379-appb-img-000075
Figure PCTKR2022010379-appb-img-000075
7-브로모퀴놀린-8-아민대신 6-브로모퀴놀린-5-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (3-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-d-4를 제조하였다.Use 6-bromoquinolin-5-amine instead of 7-bromoquinolin-8-amine, and (3-chloro-2-methoxyphenyl)boronic acid instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-d-4 was prepared in the same manner as in Preparation Example 13, except for using.
제조예 29Production Example 29
Figure PCTKR2022010379-appb-img-000076
Figure PCTKR2022010379-appb-img-000076
7-브로모퀴놀린-8-아민대신 3-브로모퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-e-1를 제조하였다.Compound B-e-1 was prepared in the same manner as in Preparation Example 13, except that 3-bromoquinolin-4-amine was used instead of 7-bromoquinolin-8-amine.
제조예 30Production Example 30
Figure PCTKR2022010379-appb-img-000077
Figure PCTKR2022010379-appb-img-000077
7-브로모퀴놀린-8-아민대신 3-브로모퀴놀린-4-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (5-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-e-2를 제조하였다.Use 3-bromoquinolin-4-amine instead of 7-bromoquinolin-8-amine, and (5-chloro-2-methoxyphenyl)boronic acid instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-e-2 was prepared in the same manner as in Preparation Example 13, except for using.
제조예 31Preparation Example 31
Figure PCTKR2022010379-appb-img-000078
Figure PCTKR2022010379-appb-img-000078
7-브로모퀴놀린-8-아민대신 3-브로모퀴놀린-4-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (4-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-e-3를 제조하였다.Use 3-bromoquinolin-4-amine instead of 7-bromoquinolin-8-amine, and (4-chloro-2-methoxyphenyl)boronic acid instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-e-3 was prepared in the same manner as in Preparation Example 13, except for using.
제조예 32Preparation Example 32
Figure PCTKR2022010379-appb-img-000079
Figure PCTKR2022010379-appb-img-000079
7-브로모퀴놀린-8-아민대신 3-브로모퀴놀린-4-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (3-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-e-4를 제조하였다.Use 3-bromoquinolin-4-amine instead of 7-bromoquinolin-8-amine, and (3-chloro-2-methoxyphenyl)boronic acid instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-e-4 was prepared in the same manner as in Preparation Example 13, except for using.
제조예 33Preparation Example 33
Figure PCTKR2022010379-appb-img-000080
Figure PCTKR2022010379-appb-img-000080
7-브로모퀴놀린-8-아민대신 3-브로모이소퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-f-1를 제조하였다.Compound B-f-1 was prepared in the same manner as in Preparation Example 13, except that 3-bromoisoquinolin-4-amine was used instead of 7-bromoquinolin-8-amine.
제조예 34Preparation Example 34
Figure PCTKR2022010379-appb-img-000081
Figure PCTKR2022010379-appb-img-000081
7-브로모퀴놀린-8-아민대신 3-브로모이소퀴놀린-4-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (5-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-f-2를 제조하였다.Use 3-bromoisoquinolin-4-amine instead of 7-bromoquinolin-8-amine, and (5-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-f-2 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 35Production Example 35
Figure PCTKR2022010379-appb-img-000082
Figure PCTKR2022010379-appb-img-000082
7-브로모퀴놀린-8-아민대신 3-브로모이소퀴놀린-4-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (4-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-f-3를 제조하였다.Use 3-bromoisoquinolin-4-amine instead of 7-bromoquinolin-8-amine, and (4-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-f-3 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 36Preparation Example 36
Figure PCTKR2022010379-appb-img-000083
Figure PCTKR2022010379-appb-img-000083
7-브로모퀴놀린-8-아민대신 3-브로모이소퀴놀린-4-아민을 사용하고, (2-클로로-6-메톡시페닐)보론산 대신 (3-클로로-2-메톡시페닐)보론산을 사용한 것을 제외하고는 제조예 13과 같은 방법으로 화합물 B-f-4를 제조하였다.Use 3-bromoisoquinolin-4-amine instead of 7-bromoquinolin-8-amine, and (3-chloro-2-methoxyphenyl)boron instead of (2-chloro-6-methoxyphenyl)boronic acid. Compound B-f-4 was prepared in the same manner as in Preparation Example 13, except that an acid was used.
제조예 37Preparation Example 37
Figure PCTKR2022010379-appb-img-000084
Figure PCTKR2022010379-appb-img-000084
2-브로모피리딘-3-아민(15 g, 86.7 mmol)과 (7-클로로-1-메톡시나프탈렌-2-일)보론산(21.5 g, 91 mmol)을 테트라하이드로퓨란(300 ml)에 넣고 교반 및 환류하였다. 이 후 포타슘 카보네이트(35.9 g, 260.1 mmol)를 물(108 ml)에 녹여 투입하고 충분히 교반한 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.9 mmol)을 투입하였다. 3 시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 C-a-1_P1를 17 g 제조하였다. (수율 69%, MS: [M+H]+= 285)2-Bromopyridin-3-amine (15 g, 86.7 mmol) and (7-chloro-1-methoxynaphthalen-2-yl) boronic acid (21.5 g, 91 mmol) were dissolved in tetrahydrofuran (300 ml). It was added and stirred and refluxed. After dissolving potassium carbonate (35.9 g, 260.1 mmol) in water (108 ml), it was added, and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.9 mmol) was added. After reacting for 3 hours, the reaction mixture was cooled to room temperature, and the organic layer was distilled after separating the organic layer and the water layer. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 17 g of compound Ca-1_P1. (Yield 69%, MS: [M+H] + = 285)
화합물 C-a-1_P1(10 g, 35.1 mmol)와 HBF4(6.2 g, 70.2 mmol)를 아세토니트릴(100 ml)에 넣고 교반하였다. 이 후 NaNO2(4.8 g, 70.2 mmol)를 H2O (20 ml)에 녹여서 0℃에서 천천히 넣어주었다. 10 시간 반응 후 이를 실온까지 승온 후, 물(200 ml)를 넣어 희석하였다. 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 C-a-1를 6.0 g 제조하였다. (수율 67%, MS: [M+H]+= 254)Compound Ca-1_P1 (10 g, 35.1 mmol) and HBF 4 (6.2 g, 70.2 mmol) were put in acetonitrile (100 ml) and stirred. Thereafter, NaNO 2 (4.8 g, 70.2 mmol) was dissolved in H 2 O (20 ml) and added slowly at 0°C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with water (200 ml). After completely dissolving in chloroform and washing twice with water, the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 6.0 g of compound Ca-1. (Yield 67%, MS: [M+H] + = 254)
제조예 38Production Example 38
Figure PCTKR2022010379-appb-img-000085
Figure PCTKR2022010379-appb-img-000085
(7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (6-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-a-2를 제조하였다.Compound C-a in the same manner as in Preparation Example 37, except that (6-chloro-1-methoxynaphthalen-2-yl) boronic acid was used instead of (7-chloro-1-methoxynaphthalen-2-yl) boronic acid. -2 was prepared.
제조예 39Preparation Example 39
Figure PCTKR2022010379-appb-img-000086
Figure PCTKR2022010379-appb-img-000086
(7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (5-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-a-3를 제조하였다.Compound C-a in the same manner as in Preparation Example 37, except that (5-chloro-1-methoxynaphthalen-2-yl) boronic acid was used instead of (7-chloro-1-methoxynaphthalen-2-yl)boronic acid. -3 was prepared.
제조예 40Production Example 40
Figure PCTKR2022010379-appb-img-000087
Figure PCTKR2022010379-appb-img-000087
(7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (4-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-a-4를 제조하였다.Compound C-a in the same manner as in Preparation Example 37, except that (4-chloro-1-methoxynaphthalen-2-yl) boronic acid was used instead of (7-chloro-1-methoxynaphthalen-2-yl)boronic acid. -4 was prepared.
제조예 41Preparation Example 41
Figure PCTKR2022010379-appb-img-000088
Figure PCTKR2022010379-appb-img-000088
(7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (3-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-a-5를 제조하였다.Compound C-a in the same manner as in Preparation Example 37, except that (3-chloro-1-methoxynaphthalen-2-yl) boronic acid was used instead of (7-chloro-1-methoxynaphthalen-2-yl)boronic acid. -5 was prepared.
제조예 42Production Example 42
Figure PCTKR2022010379-appb-img-000089
Figure PCTKR2022010379-appb-img-000089
(7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (8-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-a-6를 제조하였다.Compound C-a in the same manner as in Preparation Example 37, except that (8-chloro-1-methoxynaphthalen-2-yl) boronic acid was used instead of (7-chloro-1-methoxynaphthalen-2-yl) boronic acid. -6 was prepared.
제조예 43Production Example 43
Figure PCTKR2022010379-appb-img-000090
Figure PCTKR2022010379-appb-img-000090
2-브로모피리딘-3-아민 대신 3-브로모피리딘-4-아민을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-b-1를 제조하였다.Compound C-b-1 was prepared in the same manner as in Preparation Example 37, except that 3-bromopyridin-4-amine was used instead of 2-bromopyridin-3-amine.
제조예 44Production Example 44
Figure PCTKR2022010379-appb-img-000091
Figure PCTKR2022010379-appb-img-000091
2-브로모피리딘-3-아민 대신 3-브로모피리딘-4-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (6-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-b-2를 제조하였다.Use 3-bromopyridin-4-amine instead of 2-bromopyridin-3-amine, and (6-chloro-1-methoxy Compound C-b-2 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 45Production Example 45
Figure PCTKR2022010379-appb-img-000092
Figure PCTKR2022010379-appb-img-000092
2-브로모피리딘-3-아민 대신 3-브로모피리딘-4-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (5-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-b-3를 제조하였다.Use 3-bromopyridin-4-amine instead of 2-bromopyridin-3-amine, and (5-chloro-1-methoxy Compound C-b-3 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 46Production Example 46
Figure PCTKR2022010379-appb-img-000093
Figure PCTKR2022010379-appb-img-000093
2-브로모피리딘-3-아민 대신 3-브로모피리딘-4-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (4-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-b-4를 제조하였다.Use 3-bromopyridin-4-amine instead of 2-bromopyridin-3-amine, and (4-chloro-1-methoxy Compound C-b-4 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 47Production Example 47
Figure PCTKR2022010379-appb-img-000094
Figure PCTKR2022010379-appb-img-000094
2-브로모피리딘-3-아민 대신 3-브로모피리딘-4-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (3-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-b-5를 제조하였다.Use 3-bromopyridin-4-amine instead of 2-bromopyridin-3-amine, and (3-chloro-1-methoxy Compound C-b-5 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 48Production Example 48
Figure PCTKR2022010379-appb-img-000095
Figure PCTKR2022010379-appb-img-000095
2-브로모피리딘-3-아민 대신 3-브로모피리딘-4-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (8-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-b-6를 제조하였다.3-bromopyridin-4-amine is used instead of 2-bromopyridin-3-amine, and (8-chloro-1-methoxy Compound C-b-6 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 49Production Example 49
Figure PCTKR2022010379-appb-img-000096
Figure PCTKR2022010379-appb-img-000096
2-브로모피리딘-3-아민 대신 4-브로모피리딘-3-아민을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-c-1를 제조하였다.Compound C-c-1 was prepared in the same manner as in Preparation Example 37, except that 4-bromopyridin-3-amine was used instead of 2-bromopyridin-3-amine.
제조예 50Preparation Example 50
Figure PCTKR2022010379-appb-img-000097
Figure PCTKR2022010379-appb-img-000097
2-브로모피리딘-3-아민 대신 4-브로모피리딘-3-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (6-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-c-2를 제조하였다.Use 4-bromopyridin-3-amine instead of 2-bromopyridin-3-amine, and (6-chloro-1-methoxy Compound C-c-2 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 51Preparation Example 51
Figure PCTKR2022010379-appb-img-000098
Figure PCTKR2022010379-appb-img-000098
2-브로모피리딘-3-아민 대신 4-브로모피리딘-3-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (5-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-c-3를 제조하였다.Use 4-bromopyridin-3-amine instead of 2-bromopyridin-3-amine, and (5-chloro-1-methoxy Compound C-c-3 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 52Preparation Example 52
Figure PCTKR2022010379-appb-img-000099
Figure PCTKR2022010379-appb-img-000099
2-브로모피리딘-3-아민 대신 4-브로모피리딘-3-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (4-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-c-4를 제조하였다.Use 4-bromopyridin-3-amine instead of 2-bromopyridin-3-amine, and (4-chloro-1-methoxy Compound C-c-4 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 53Production Example 53
Figure PCTKR2022010379-appb-img-000100
Figure PCTKR2022010379-appb-img-000100
2-브로모피리딘-3-아민 대신 4-브로모피리딘-3-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (3-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-c-5를 제조하였다.Use 4-bromopyridin-3-amine instead of 2-bromopyridin-3-amine, and (3-chloro-1-methoxy Compound C-c-5 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 54Preparation Example 54
Figure PCTKR2022010379-appb-img-000101
Figure PCTKR2022010379-appb-img-000101
2-브로모피리딘-3-아민 대신 4-브로모피리딘-3-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (8-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-c-6를 제조하였다.Use 4-bromopyridin-3-amine instead of 2-bromopyridin-3-amine, and (8-chloro-1-methoxy Compound C-c-6 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 55Preparation Example 55
Figure PCTKR2022010379-appb-img-000102
Figure PCTKR2022010379-appb-img-000102
2-브로모피리딘-3-아민 대신 3-브로모피리딘-2-아민을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-d-1를 제조하였다.Compound C-d-1 was prepared in the same manner as in Preparation Example 37, except that 3-bromopyridin-2-amine was used instead of 2-bromopyridin-3-amine.
제조예 56Preparation Example 56
Figure PCTKR2022010379-appb-img-000103
Figure PCTKR2022010379-appb-img-000103
2-브로모피리딘-3-아민 대신 3-브로모피리딘-2-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (6-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-d-2를 제조하였다.3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, and (6-chloro-1-methoxy Compound C-d-2 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 57Preparation Example 57
Figure PCTKR2022010379-appb-img-000104
Figure PCTKR2022010379-appb-img-000104
2-브로모피리딘-3-아민 대신 3-브로모피리딘-2-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (5-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-d-3를 제조하였다.3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, and (5-chloro-1-methoxy Compound C-d-3 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 58Preparation Example 58
Figure PCTKR2022010379-appb-img-000105
Figure PCTKR2022010379-appb-img-000105
2-브로모피리딘-3-아민 대신 3-브로모피리딘-2-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (4-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-d-4를 제조하였다.3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, (4-chloro-1-methoxy Compound C-d-4 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 59Preparation Example 59
Figure PCTKR2022010379-appb-img-000106
Figure PCTKR2022010379-appb-img-000106
2-브로모피리딘-3-아민 대신 3-브로모피리딘-2-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (3-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-d-5를 제조하였다.Use 3-bromopyridin-2-amine instead of 2-bromopyridin-3-amine, and (3-chloro-1-methoxy Compound C-d-5 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 60Preparation Example 60
Figure PCTKR2022010379-appb-img-000107
s
Figure PCTKR2022010379-appb-img-000107
s
2-브로모피리딘-3-아민 대신 3-브로모피리딘-2-아민을 사용하고, (7-클로로-1-메톡시나프탈렌-2-일)보론산 대신 (8-클로로-1-메톡시나프탈렌-2-일)보론산을 사용한 것을 제외하고는 제조예 37과 같은 방법으로 화합물 C-d-6를 제조하였다.3-bromopyridin-2-amine is used instead of 2-bromopyridin-3-amine, and (8-chloro-1-methoxy Compound C-d-6 was prepared in the same manner as in Preparation Example 37, except that naphthalen-2-yl)boronic acid was used.
제조예 61Preparation Example 61
Figure PCTKR2022010379-appb-img-000108
Figure PCTKR2022010379-appb-img-000108
3-브로모-6-클로로이소퀴놀린-4-아민(15 g, 58.2 mmol)과 (2-메톡시페닐)보론산(9.3 g, 61.2 mmol)를 테트라하이드로퓨란(300 ml)에 넣고 교반 및 환류하였다. 이 후 포타슘 카보네이트(24.2 g, 174.7 mmol)를 물(72 ml)에 녹여 투입하고 충분히 교반한 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.3 g, 0.6 mmol)을 투입하였다. 5 시간 반응 후 상온으로 식히고 유기층과 물층을 분리 후 유기층을 증류하였다. 이를 다시 클로로포름에 녹이고, 물로 2회 세척 후에 유기층을 분리하여, 무수황산마그네슘을 넣고 교반한 후 여과하여 여액을 감압 증류하였다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제하여 화합물 C-a-1_P1를 10.8g 제조하였다. (수율 65%, MS: [M+H]+= 285)3-Bromo-6-chloroisoquinolin-4-amine (15 g, 58.2 mmol) and (2-methoxyphenyl) boronic acid (9.3 g, 61.2 mmol) were added to tetrahydrofuran (300 ml), stirred and refluxed. Thereafter, potassium carbonate (24.2 g, 174.7 mmol) was dissolved in water (72 ml), and after stirring sufficiently, bis(tri-tert-butylphosphine)palladium(0) (0.3 g, 0.6 mmol) was added. After reacting for 5 hours, the mixture was cooled to room temperature, and an organic layer and an aqueous layer were separated, and the organic layer was distilled. This was dissolved in chloroform again, and after washing twice with water, the organic layer was separated, stirred with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 10.8 g of compound Ca-1_P1. (Yield 65%, MS: [M+H] + = 285)
화합물 D-a-1_P1(10 g, 35.1 mmol)와 HBF4(6.2 g, 70.2 mmol)를 아세토니트릴(100 ml)에 넣고 교반하였다. 이 후 NaNO2(4.8 g, 70.2 mmol)를 H2O(20 ml)에 녹여서 0℃에서 천천히 넣어주었다. 10 시간 반응 후 이를 실온까지 승온 후, 물(200 ml)를 넣어 희석하였다. 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 D-a-1를 5.4g 제조하였다. (수율 61%, MS: [M+H]+= 254)Compound Da-1_P1 (10 g, 35.1 mmol) and HBF 4 (6.2 g, 70.2 mmol) were put in acetonitrile (100 ml) and stirred. Thereafter, NaNO 2 (4.8 g, 70.2 mmol) was dissolved in H 2 O (20 ml) and added slowly at 0°C. After reacting for 10 hours, the temperature was raised to room temperature, and diluted with water (200 ml). After completely dissolving in chloroform and washing twice with water, the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to prepare 5.4 g of compound Da-1. (Yield 61%, MS: [M+H] + = 254)
제조예 62Preparation Example 62
Figure PCTKR2022010379-appb-img-000109
Figure PCTKR2022010379-appb-img-000109
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-7-클로로이소퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-a-2를 제조하였다.Compound D-a-2 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-7-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 63Preparation Example 63
Figure PCTKR2022010379-appb-img-000110
Figure PCTKR2022010379-appb-img-000110
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-8-클로로이소퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-a-3를 제조하였다.Compound D-a-3 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-8-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 64Preparation Example 64
Figure PCTKR2022010379-appb-img-000111
Figure PCTKR2022010379-appb-img-000111
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-1-클로로이소퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-a-4를 제조하였다.Compound D-a-4 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-1-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 65Preparation Example 65
Figure PCTKR2022010379-appb-img-000112
Figure PCTKR2022010379-appb-img-000112
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-5-클로로이소퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-a-5를 제조하였다.Compound D-a-5 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-5-chloroisoquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 66Preparation Example 66
Figure PCTKR2022010379-appb-img-000113
Figure PCTKR2022010379-appb-img-000113
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-2-클로로퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-b-1를 제조하였다.Compound D-b-1 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-2-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 67Preparation Example 67
Figure PCTKR2022010379-appb-img-000114
Figure PCTKR2022010379-appb-img-000114
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-3-클로로퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-b-2를 제조하였다.Compound D-b-2 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-3-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 68Preparation Example 68
Figure PCTKR2022010379-appb-img-000115
Figure PCTKR2022010379-appb-img-000115
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-4-클로로퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-b-3를 제조하였다.Compound D-b-3 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-4-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 69Preparation Example 69
Figure PCTKR2022010379-appb-img-000116
Figure PCTKR2022010379-appb-img-000116
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-5-클로로퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-b-4를 제조하였다.Compound D-b-4 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-5-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 70Production Example 70
Figure PCTKR2022010379-appb-img-000117
Figure PCTKR2022010379-appb-img-000117
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-6-클로로퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-b-5를 제조하였다.Compound D-b-5 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-6-chloroquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 71Production Example 71
Figure PCTKR2022010379-appb-img-000118
Figure PCTKR2022010379-appb-img-000118
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-3-클로로이소퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-c-1를 제조하였다.Compound D-c-1 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-3-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 72Preparation Example 72
Figure PCTKR2022010379-appb-img-000119
Figure PCTKR2022010379-appb-img-000119
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-4-클로로이소퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-c-2를 제조하였다.Compound D-c-2 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-4-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 73Production Example 73
Figure PCTKR2022010379-appb-img-000120
Figure PCTKR2022010379-appb-img-000120
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-5-클로로이소퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-c-3를 제조하였다.Compound D-c-3 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-5-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 74Production Example 74
Figure PCTKR2022010379-appb-img-000121
Figure PCTKR2022010379-appb-img-000121
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-6-클로로이소퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-c-4를 제조하였다.Compound D-c-4 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-6-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 75Production Example 75
Figure PCTKR2022010379-appb-img-000122
Figure PCTKR2022010379-appb-img-000122
3-브로모-6-클로로이소퀴놀린-4-아민 대신 7-브로모-1-클로로이소퀴놀린-8-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-c-5를 제조하였다.Compound D-c-5 was prepared in the same manner as in Preparation Example 61, except that 7-bromo-1-chloroisoquinolin-8-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 76Production Example 76
Figure PCTKR2022010379-appb-img-000123
Figure PCTKR2022010379-appb-img-000123
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-3-클로로이소퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-d-1를 제조하였다.Compound D-d-1 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-3-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 77Preparation Example 77
Figure PCTKR2022010379-appb-img-000124
Figure PCTKR2022010379-appb-img-000124
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-1-클로로이소퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-d-2를 제조하였다.Compound D-d-2 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-1-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 78Preparation Example 78
Figure PCTKR2022010379-appb-img-000125
Figure PCTKR2022010379-appb-img-000125
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-8-클로로이소퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-d-3를 제조하였다.Compound D-d-3 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-8-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 79Production Example 79
Figure PCTKR2022010379-appb-img-000126
Figure PCTKR2022010379-appb-img-000126
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-7-클로로이소퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-d-4를 제조하였다.Compound D-d-4 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-7-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 80Preparation Example 80
Figure PCTKR2022010379-appb-img-000127
Figure PCTKR2022010379-appb-img-000127
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-4-클로로이소퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-d-5를 제조하였다.Compound D-d-5 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-4-chloroisoquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 81Preparation Example 81
Figure PCTKR2022010379-appb-img-000128
Figure PCTKR2022010379-appb-img-000128
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-3-클로로퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-e-1를 제조하였다.Compound D-e-1 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-3-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 82Preparation Example 82
Figure PCTKR2022010379-appb-img-000129
Figure PCTKR2022010379-appb-img-000129
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-2-클로로퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-e-2를 제조하였다.Compound D-e-2 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-2-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 83Preparation Example 83
Figure PCTKR2022010379-appb-img-000130
Figure PCTKR2022010379-appb-img-000130
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-8-클로로퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-e-3를 제조하였다.Compound D-e-3 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-8-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 84Preparation Example 84
Figure PCTKR2022010379-appb-img-000131
Figure PCTKR2022010379-appb-img-000131
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-7-클로로퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-e-4를 제조하였다.Compound D-e-4 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-7-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 85Preparation Example 85
Figure PCTKR2022010379-appb-img-000132
Figure PCTKR2022010379-appb-img-000132
3-브로모-6-클로로이소퀴놀린-4-아민 대신 6-브로모-4-클로로퀴놀린-5-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-e-5를 제조하였다.Compound D-e-5 was prepared in the same manner as in Preparation Example 61, except that 6-bromo-4-chloroquinolin-5-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 86Preparation Example 86
Figure PCTKR2022010379-appb-img-000133
Figure PCTKR2022010379-appb-img-000133
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-6-클로로퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-f-1를 제조하였다.Compound D-f-1 was prepared in the same manner as in Preparation Example 61, except for using 3-bromo-6-chloroisoquinolin-4-amine instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 87Preparation Example 87
Figure PCTKR2022010379-appb-img-000134
Figure PCTKR2022010379-appb-img-000134
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-7-클로로퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-f-2를 제조하였다.Compound D-f-2 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-7-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 88Preparation Example 88
Figure PCTKR2022010379-appb-img-000135
Figure PCTKR2022010379-appb-img-000135
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-8-클로로퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-f-3를 제조하였다.Compound D-f-3 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-8-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 89Preparation Example 89
Figure PCTKR2022010379-appb-img-000136
Figure PCTKR2022010379-appb-img-000136
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-2-클로로퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-f-4를 제조하였다.Compound D-f-4 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-2-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
제조예 90Preparation Example 90
Figure PCTKR2022010379-appb-img-000137
Figure PCTKR2022010379-appb-img-000137
3-브로모-6-클로로이소퀴놀린-4-아민 대신 3-브로모-5-클로로퀴놀린-4-아민을 사용한 것을 제외하고는 제조예 61과 같은 방법으로 화합물 D-f-5를 제조하였다.Compound D-f-5 was prepared in the same manner as in Preparation Example 61, except that 3-bromo-5-chloroquinolin-4-amine was used instead of 3-bromo-6-chloroisoquinolin-4-amine.
[합성예][Synthesis Example]
합성예 1Synthesis Example 1
Figure PCTKR2022010379-appb-img-000138
Figure PCTKR2022010379-appb-img-000138
질소 분위기에서 화합물 A-a-2(10 g, 39.4 mmol), 아민 1(16.2 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 1 15.6 g을 얻었다. (수율 63%, MS: [M+H]+= 628)In a nitrogen atmosphere, compound Aa-2 (10 g, 39.4 mmol), amine 1 (16.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.6 g of Compound 1. (Yield 63%, MS: [M+H] + = 628)
합성예 2Synthesis Example 2
Figure PCTKR2022010379-appb-img-000139
Figure PCTKR2022010379-appb-img-000139
질소 분위기에서 화합물 A-a-3(10 g, 39.4 mmol), 아민 2 (13.8 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 2 15.6 g을 얻었다. (수율 70%, MS: [M+H]+= 567)In a nitrogen atmosphere, compound Aa-3 (10 g, 39.4 mmol), amine 2 (13.8 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.6 g of Compound 2. (Yield 70%, MS: [M+H] + = 567)
합성예 3Synthesis Example 3
Figure PCTKR2022010379-appb-img-000140
Figure PCTKR2022010379-appb-img-000140
질소 분위기에서 화합물 A-b-1(10 g, 39.4 mmol), 아민 3(22.1 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 3 22.1 g을 얻었다. (수율 72%, MS: [M+H]+= 779)In a nitrogen atmosphere, compound Ab-1 (10 g, 39.4 mmol), amine 3 (22.1 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 22.1 g of Compound 3. (Yield 72%, MS: [M+H] + = 779)
합성예 4Synthesis Example 4
Figure PCTKR2022010379-appb-img-000141
Figure PCTKR2022010379-appb-img-000141
질소 분위기에서 화합물 A-b-1(10 g, 39.4 mmol), 아민 4(14.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 4 14.4 g을 얻었다. (수율 62%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Ab-1 (10 g, 39.4 mmol), amine 4 (14.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.4 g of Compound 4. (Yield 62%, MS: [M+H] + = 589)
합성예 5Synthesis Example 5
Figure PCTKR2022010379-appb-img-000142
Figure PCTKR2022010379-appb-img-000142
질소 분위기에서 화합물 A-b-2(10 g, 39.4 mmol), 아민 5(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 5 17.5 g을 얻었다. (수율 67%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Ab-2 (10 g, 39.4 mmol), amine 5 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17.5 g of Compound 5. (Yield 67%, MS: [M+H] + = 665)
합성예 6Synthesis Example 6
Figure PCTKR2022010379-appb-img-000143
Figure PCTKR2022010379-appb-img-000143
질소 분위기에서 화합물 A-c-1(10 g, 39.4 mmol), 아민 6(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 6 15.2 g을 얻었다. (수율 58%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Ac-1 (10 g, 39.4 mmol), amine 6 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.2 g of Compound 6. (Yield 58%, MS: [M+H] + = 665)
합성예 7Synthesis Example 7
Figure PCTKR2022010379-appb-img-000144
Figure PCTKR2022010379-appb-img-000144
질소 분위기에서 화합물 A-c-2(10 g, 39.4 mmol), 아민 7(15.7 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 7 15.7 g을 얻었다. (수율 65%, MS: [M+H]+= 615)In a nitrogen atmosphere, compound Ac-2 (10 g, 39.4 mmol), amine 7 (15.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.7 g of Compound 7. (Yield 65%, MS: [M+H] + = 615)
합성예 8Synthesis Example 8
Figure PCTKR2022010379-appb-img-000145
Figure PCTKR2022010379-appb-img-000145
질소 분위기에서 화합물 A-c-2(10 g, 39.4 mmol), 아민 8(13.9 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 8 15.7 g을 얻었다. (수율 70%, MS: [M+H]+= 569)In a nitrogen atmosphere, compound Ac-2 (10 g, 39.4 mmol), amine 8 (13.9 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.7 g of Compound 8. (Yield 70%, MS: [M+H] + = 569)
합성예 9Synthesis Example 9
Figure PCTKR2022010379-appb-img-000146
Figure PCTKR2022010379-appb-img-000146
질소 분위기에서 화합물 A-c-2(10 g, 39.4 mmol), 아민 9(12.7 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 9 14.6 g을 얻었다. (수율 69%, MS: [M+H]+= 539)In a nitrogen atmosphere, compound Ac-2 (10 g, 39.4 mmol), amine 9 (12.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.6 g of Compound 9. (Yield 69%, MS: [M+H] + = 539)
합성예 10Synthesis Example 10
Figure PCTKR2022010379-appb-img-000147
Figure PCTKR2022010379-appb-img-000147
질소 분위기에서 화합물 A-d-1(10 g, 39.4 mmol), 아민 10(12.7 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 10 14.4 g을 얻었다. (수율 68%, MS: [M+H]+= 539)In a nitrogen atmosphere, compound Ad-1 (10 g, 39.4 mmol), amine 10 (12.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.4 g of Compound 10. (Yield 68%, MS: [M+H] + = 539)
합성예 11Synthesis Example 11
Figure PCTKR2022010379-appb-img-000148
Figure PCTKR2022010379-appb-img-000148
질소 분위기에서 화합물 A-d-2(10 g, 39.4 mmol), 아민 11(16.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 11 16.4 g을 얻었다. (수율 65%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Ad-2 (10 g, 39.4 mmol), amine 11 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.4 g of Compound 11. (Yield 65%, MS: [M+H] + = 639)
합성예 12Synthesis Example 12
Figure PCTKR2022010379-appb-img-000149
Figure PCTKR2022010379-appb-img-000149
질소 분위기에서 화합물 A-d-3(10 g, 39.4 mmol), 아민 12(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 12 18.1 g을 얻었다. (수율 69%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Ad-3 (10 g, 39.4 mmol), amine 12 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 18.1 g of Compound 12. (Yield 69%, MS: [M+H] + = 665)
합성예 13Synthesis Example 13
Figure PCTKR2022010379-appb-img-000150
Figure PCTKR2022010379-appb-img-000150
질소 분위기에서 화합물 A-d-3(10 g, 39.4 mmol), 아민 13(14.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)을 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 13 14.1 g을 얻었다. (수율 61%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Ad-3 (10 g, 39.4 mmol), amine 13 (14.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.1 g of Compound 13. (Yield 61%, MS: [M+H] + = 589)
합성예 14Synthesis Example 14
Figure PCTKR2022010379-appb-img-000151
Figure PCTKR2022010379-appb-img-000151
질소 분위기에서 화합물 A-d-3(10 g, 39.4 mmol), 아민 14(16.2 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 14 14.4 g을 얻었다. (수율 58%, MS: [M+H]+= 629)In a nitrogen atmosphere, compound Ad-3 (10 g, 39.4 mmol), amine 14 (16.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.4 g of Compound 14. (Yield 58%, MS: [M+H] + = 629)
합성예 15Synthesis Example 15
Figure PCTKR2022010379-appb-img-000152
Figure PCTKR2022010379-appb-img-000152
질소 분위기에서 화합물 B-a-1(10 g, 39.4 mmol), 아민 13(14.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 15 13.4 g을 얻었다. (수율 58%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Ba-1 (10 g, 39.4 mmol), amine 13 (14.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 13.4 g of Compound 15. (Yield 58%, MS: [M+H] + = 589)
합성예 16Synthesis Example 16
Figure PCTKR2022010379-appb-img-000153
Figure PCTKR2022010379-appb-img-000153
질소 분위기에서 화합물 B-a-3(10 g, 39.4 mmol), 아민 15(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 16 16.2 g을 얻었다. (수율 62%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Ba-3 (10 g, 39.4 mmol), amine 15 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.2 g of Compound 16. (Yield 62%, MS: [M+H] + = 665)
합성예 17Synthesis Example 17
Figure PCTKR2022010379-appb-img-000154
Figure PCTKR2022010379-appb-img-000154
질소 분위기에서 화합물 B-a-4(10 g, 39.4 mmol), 아민 16(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 17 17 g을 얻었다. (수율 65%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Ba-4 (10 g, 39.4 mmol), amine 16 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17 g of Compound 17. (Yield 65%, MS: [M+H] + = 665)
합성예 18Synthesis Example 18
Figure PCTKR2022010379-appb-img-000155
Figure PCTKR2022010379-appb-img-000155
질소 분위기에서 화합물 B-b-2(10 g, 39.4 mmol), 아민 17(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 18 17 g을 얻었다. (수율 65%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Bb-2 (10 g, 39.4 mmol), amine 17 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17 g of Compound 18. (Yield 65%, MS: [M+H] + = 665)
합성예 19Synthesis Example 19
Figure PCTKR2022010379-appb-img-000156
Figure PCTKR2022010379-appb-img-000156
질소 분위기에서 화합물 B-c-1(10 g, 39.4 mmol), 아민 18(13.2 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 19 13.7 g을 얻었다. (수율 63%, MS: [M+H]+= 553)In a nitrogen atmosphere, compound Bc-1 (10 g, 39.4 mmol), amine 18 (13.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 13.7 g of Compound 19. (Yield 63%, MS: [M+H] + = 553)
합성예 20Synthesis Example 20
Figure PCTKR2022010379-appb-img-000157
Figure PCTKR2022010379-appb-img-000157
질소 분위기에서 화합물 B-c-3(10 g, 39.4 mmol), 아민 19(16.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 20 16.6 g을 얻었다. (수율 66%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Bc-3 (10 g, 39.4 mmol), amine 19 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.6 g of Compound 20. (Yield 66%, MS: [M+H] + = 639)
합성예 21Synthesis Example 21
Figure PCTKR2022010379-appb-img-000158
Figure PCTKR2022010379-appb-img-000158
질소 분위기에서 화합물 B-d-1(10 g, 39.4 mmol), 아민 20(16.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 21 16.9 g을 얻었다. (수율 67%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Bd-1 (10 g, 39.4 mmol), amine 20 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.9 g of Compound 21. (Yield 67%, MS: [M+H] + = 639)
합성예 22Synthesis Example 22
Figure PCTKR2022010379-appb-img-000159
Figure PCTKR2022010379-appb-img-000159
질소 분위기에서 화합물 B-d-2(10 g, 39.4 mmol), 아민 15(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 22 17.3 g을 얻었다. (수율 66%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Bd-2 (10 g, 39.4 mmol), amine 15 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17.3 g of Compound 22. (Yield 66%, MS: [M+H] + = 665)
합성예 23Synthesis Example 23
Figure PCTKR2022010379-appb-img-000160
Figure PCTKR2022010379-appb-img-000160
질소 분위기에서 화합물 B-d-3(10 g, 39.4 mmol), 아민 21(14.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 23 14.1 g을 얻었다. (수율 61%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Bd-3 (10 g, 39.4 mmol), amine 21 (14.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.1 g of Compound 23. (Yield 61%, MS: [M+H] + = 589)
합성예 24Synthesis Example 24
Figure PCTKR2022010379-appb-img-000161
Figure PCTKR2022010379-appb-img-000161
질소 분위기에서 화합물 B-d-3(10 g, 39.4 mmol), 아민 22(15.7 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 24 14 g을 얻었다. (수율 58%, MS: [M+H]+= 615)In a nitrogen atmosphere, compound Bd-3 (10 g, 39.4 mmol), amine 22 (15.7 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14 g of Compound 24. (Yield 58%, MS: [M+H] + = 615)
합성예 25Synthesis Example 25
Figure PCTKR2022010379-appb-img-000162
Figure PCTKR2022010379-appb-img-000162
질소 분위기에서 화합물 B-d-3(10 g, 39.4 mmol), 아민 23(13.9 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 25 14.8 g을 얻었다. (수율 66%, MS: [M+H]+= 569)In a nitrogen atmosphere, compound Bd-3 (10 g, 39.4 mmol), amine 23 (13.9 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.8 g of Compound 25. (Yield 66%, MS: [M+H] + = 569)
합성예 26Synthesis Example 26
Figure PCTKR2022010379-appb-img-000163
Figure PCTKR2022010379-appb-img-000163
질소 분위기에서 화합물 B-d-4(10 g, 39.4 mmol), 아민 24(14.2 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 26 15.5 g을 얻었다. (수율 68%, MS: [M+H]+= 579)In a nitrogen atmosphere, compound Bd-4 (10 g, 39.4 mmol), amine 24 (14.2 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.5 g of Compound 26. (Yield 68%, MS: [M+H] + = 579)
합성예 27Synthesis Example 27
Figure PCTKR2022010379-appb-img-000164
Figure PCTKR2022010379-appb-img-000164
질소 분위기에서 화합물 B-e-1(10 g, 39.4 mmol), 아민 25(16.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 27 16.6 g을 얻었다. (수율 66%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Be-1 (10 g, 39.4 mmol), amine 25 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.6 g of Compound 27. (Yield 66%, MS: [M+H] + = 639)
합성예 28Synthesis Example 28
Figure PCTKR2022010379-appb-img-000165
Figure PCTKR2022010379-appb-img-000165
질소 분위기에서 화합물 B-e-4(10 g, 39.4 mmol), 아민 26(16.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 28 18.1 g을 얻었다. (수율 72%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Be-4 (10 g, 39.4 mmol), amine 26 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 18.1 g of Compound 28. (Yield 72%, MS: [M+H] + = 639)
합성예 29Synthesis Example 29
Figure PCTKR2022010379-appb-img-000166
Figure PCTKR2022010379-appb-img-000166
질소 분위기에서 화합물 B-e-4(10 g, 39.4 mmol), 아민 27(18.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 29 15.7 g을 얻었다. (수율 58%, MS: [M+H]+= 689)In a nitrogen atmosphere, compound Be-4 (10 g, 39.4 mmol), amine 27 (18.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.7 g of Compound 29. (Yield 58%, MS: [M+H] + = 689)
합성예 30Synthesis Example 30
Figure PCTKR2022010379-appb-img-000167
Figure PCTKR2022010379-appb-img-000167
질소 분위기에서 화합물 B-f-2(10 g, 39.4 mmol), 아민 28(17.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0) (0.2 g, 0.4 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 30 15.4 g을 얻었다. (수율 59%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Bf-2 (10 g, 39.4 mmol), amine 28 (17.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.4 g of Compound 30. (Yield 59%, MS: [M+H] + = 665)
합성예 31Synthesis Example 31
Figure PCTKR2022010379-appb-img-000168
Figure PCTKR2022010379-appb-img-000168
질소 분위기에서 화합물 B-f-3(10 g, 39.4 mmol), 아민 29(16.6 g, 39.4 mmol), 소듐 터트-부톡사이드(12.6 g, 59.1 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.2 g, 0.4 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 31 17.1 g을 얻었다. (수율 68%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Bf-3 (10 g, 39.4 mmol), amine 29 (16.6 g, 39.4 mmol), and sodium tert-butoxide (12.6 g, 59.1 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.2 g, 0.4 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17.1 g of Compound 31. (Yield 68%, MS: [M+H] + = 639)
합성예 32Synthesis Example 32
Figure PCTKR2022010379-appb-img-000169
Figure PCTKR2022010379-appb-img-000169
질소 분위기에서 화합물 C-a-1(10 g, 39.4 mmol), 아민 17(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 32 16.2 g을 얻었다. (수율 62%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Ca-1 (10 g, 39.4 mmol), amine 17 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.2 g of Compound 32. (Yield 62%, MS: [M+H] + = 665)
합성예 33Synthesis Example 33
Figure PCTKR2022010379-appb-img-000170
Figure PCTKR2022010379-appb-img-000170
질소 분위기에서 화합물 C-a-2(10 g, 39.4 mmol), 아민 30(17.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 33 15.8 g을 얻었다. (수율 63%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Ca-2 (10 g, 39.4 mmol), amine 30 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.8 g of Compound 33. (Yield 63%, MS: [M+H] + = 639)
합성예 34Synthesis Example 34
Figure PCTKR2022010379-appb-img-000171
Figure PCTKR2022010379-appb-img-000171
질소 분위기에서 화합물 C-a-4(10 g, 39.4 mmol), 아민 31(13.3 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 34 12.7 g을 얻었다. (수율 60%, MS: [M+H]+= 539)In a nitrogen atmosphere, compound Ca-4 (10 g, 39.4 mmol), amine 31 (13.3 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 12.7 g of Compound 34. (Yield 60%, MS: [M+H] + = 539)
합성예 35Synthesis Example 35
Figure PCTKR2022010379-appb-img-000172
Figure PCTKR2022010379-appb-img-000172
질소 분위기에서 화합물 C-b-2(10 g, 39.4 mmol), 아민 21(15.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 35 13.9 g을 얻었다. (수율 60%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Cb-2 (10 g, 39.4 mmol), amine 21 (15.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 13.9 g of Compound 35. (Yield 60%, MS: [M+H] + = 589)
합성예 36Synthesis Example 36
Figure PCTKR2022010379-appb-img-000173
Figure PCTKR2022010379-appb-img-000173
질소 분위기에서 화합물 C-b-3(10 g, 39.4 mmol), 아민 5(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 36 17 g을 얻었다. (수율 65%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Cb-3 (10 g, 39.4 mmol), amine 5 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17 g of Compound 36. (Yield 65%, MS: [M+H] + = 665)
합성예 37Synthesis Example 37
Figure PCTKR2022010379-appb-img-000174
Figure PCTKR2022010379-appb-img-000174
질소 분위기에서 화합물 C-b-5(10 g, 39.4 mmol), 아민 32(17.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 37 15.3 g을 얻었다. (수율 61%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Cb-5 (10 g, 39.4 mmol), amine 32 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.3 g of Compound 37. (Yield 61%, MS: [M+H] + = 639)
합성예 38Synthesis Example 38
Figure PCTKR2022010379-appb-img-000175
Figure PCTKR2022010379-appb-img-000175
질소 분위기에서 화합물 C-c-1(10 g, 39.4 mmol), 아민 33(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 38 15.2 g을 얻었다. (수율 58%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Cc-1 (10 g, 39.4 mmol), amine 33 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.2 g of Compound 38. (Yield 58%, MS: [M+H] + = 665)
합성예 39Synthesis Example 39
Figure PCTKR2022010379-appb-img-000176
Figure PCTKR2022010379-appb-img-000176
질소 분위기에서 화합물 C-c-4(10 g, 39.4 mmol), 아민 34(20.6 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 39 17.2 g을 얻었다. (수율 61%, MS: [M+H]+= 715)In a nitrogen atmosphere, compound Cc-4 (10 g, 39.4 mmol), amine 34 (20.6 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17.2 g of Compound 39. (Yield 61%, MS: [M+H] + = 715)
합성예 40Synthesis Example 40
Figure PCTKR2022010379-appb-img-000177
Figure PCTKR2022010379-appb-img-000177
질소 분위기에서 화합물 C-c-4(10 g, 39.4 mmol), 아민 35(17.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 40 14.6 g을 얻었다. (수율 58%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Cc-4 (10 g, 39.4 mmol), amine 35 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.6 g of Compound 40. (Yield 58%, MS: [M+H] + = 639)
합성예 41Synthesis Example 41
Figure PCTKR2022010379-appb-img-000178
Figure PCTKR2022010379-appb-img-000178
질소 분위기에서 화합물 C-d-3(10 g, 39.4 mmol), 아민 33(15.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 41 14.1 g을 얻었다. (수율 61%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Cd-3 (10 g, 39.4 mmol), amine 33 (15.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.1 g of Compound 41. (Yield 61%, MS: [M+H] + = 589)
합성예 42Synthesis Example 42
Figure PCTKR2022010379-appb-img-000179
Figure PCTKR2022010379-appb-img-000179
질소 분위기에서 화합물 C-d-5(10 g, 39.4 mmol), 아민 37(15.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 42 16 g을 얻었다. (수율 69%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Cd-5 (10 g, 39.4 mmol), amine 37 (15.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16 g of Compound 42. (Yield 69%, MS: [M+H] + = 589)
합성예 43Synthesis Example 43
Figure PCTKR2022010379-appb-img-000180
Figure PCTKR2022010379-appb-img-000180
질소 분위기에서 화합물 C-d-6(10 g, 39.4 mmol), 아민 38(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 43 18.1 g을 얻었다. (수율 69%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Cd-6 (10 g, 39.4 mmol), amine 38 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 18.1 g of Compound 43. (Yield 69%, MS: [M+H] + = 665)
합성예 44Synthesis Example 44
Figure PCTKR2022010379-appb-img-000181
Figure PCTKR2022010379-appb-img-000181
질소 분위기에서 화합물 D-a-1(10 g, 39.4 mmol), 아민 11(17.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 44 17.4 g을 얻었다. (수율 69%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Da-1 (10 g, 39.4 mmol), amine 11 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17.4 g of Compound 44. (Yield 69%, MS: [M+H] + = 639)
합성예 45Synthesis Example 45
Figure PCTKR2022010379-appb-img-000182
Figure PCTKR2022010379-appb-img-000182
질소 분위기에서 화합물 D-a-3(10 g, 39.4 mmol), 아민 4(15.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 45 13.9 g을 얻었다. (수율 60%, MS: [M+H]+= 589)In a nitrogen atmosphere, compound Da-3 (10 g, 39.4 mmol), amine 4 (15.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 13.9 g of Compound 45. (Yield 60%, MS: [M+H] + = 589)
합성예 46Synthesis Example 46
Figure PCTKR2022010379-appb-img-000183
Figure PCTKR2022010379-appb-img-000183
질소 분위기에서 화합물 D-a-5(10 g, 39.4 mmol), 아민 40(13.3 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 46 14.2 g을 얻었다. (수율 67%, MS: [M+H]+= 539)In a nitrogen atmosphere, compound Da-5 (10 g, 39.4 mmol), amine 40 (13.3 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.2 g of Compound 46. (Yield 67%, MS: [M+H] + = 539)
합성예 47Synthesis Example 47
Figure PCTKR2022010379-appb-img-000184
Figure PCTKR2022010379-appb-img-000184
질소 분위기에서 화합물 D-b-1(10 g, 39.4 mmol), 아민 41(19.6 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 47 17.7 g을 얻었다. (수율 65%, MS: [M+H]+= 691)In a nitrogen atmosphere, compound Db-1 (10 g, 39.4 mmol), amine 41 (19.6 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml) and stirred to reflux. Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 17.7 g of Compound 47. (Yield 65%, MS: [M+H] + = 691)
합성예 48Synthesis Example 48
Figure PCTKR2022010379-appb-img-000185
Figure PCTKR2022010379-appb-img-000185
질소 분위기에서 화합물 D-b-2(10 g, 39.4 mmol), 아민 42(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 48 16.5 g을 얻었다. (수율 63%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Db-2 (10 g, 39.4 mmol), amine 42 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.5 g of Compound 48. (Yield 63%, MS: [M+H] + = 665)
합성예 49Synthesis Example 49
Figure PCTKR2022010379-appb-img-000186
Figure PCTKR2022010379-appb-img-000186
질소 분위기에서 화합물 D-b-5(10 g, 39.4 mmol), 아민 43(16.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 49 15 g을 얻었다. (수율 62%, MS: [M+H]+= 615)In a nitrogen atmosphere, compound Db-5 (10 g, 39.4 mmol), amine 43 (16.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15 g of Compound 49. (Yield 62%, MS: [M+H] + = 615)
합성예 50Synthesis Example 50
Figure PCTKR2022010379-appb-img-000187
Figure PCTKR2022010379-appb-img-000187
질소 분위기에서 화합물 D-c-2(10 g, 39.4 mmol), 아민 44(13.3 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 50 14.6 g을 얻었다. (수율 69%, MS: [M+H]+= 539)In a nitrogen atmosphere, compound Dc-2 (10 g, 39.4 mmol), amine 44 (13.3 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 14.6 g of Compound 50. (Yield 69%, MS: [M+H] + = 539)
합성예 51Synthesis Example 51
Figure PCTKR2022010379-appb-img-000188
Figure PCTKR2022010379-appb-img-000188
질소 분위기에서 화합물 D-c-3(10 g, 39.4 mmol), 아민 17(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 51 16 g을 얻었다. (수율 61%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Dc-3 (10 g, 39.4 mmol), amine 17 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16 g of Compound 51. (Yield 61%, MS: [M+H] + = 665)
합성예 52Synthesis Example 52
Figure PCTKR2022010379-appb-img-000189
Figure PCTKR2022010379-appb-img-000189
질소 분위기에서 화합물 D-d-1(10 g, 39.4 mmol), 아민 20(17.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 52 16.9 g을 얻었다. (수율 67%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Dd-1 (10 g, 39.4 mmol), amine 20 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.9 g of Compound 52. (Yield 67%, MS: [M+H] + = 639)
합성예 53Synthesis Example 53
Figure PCTKR2022010379-appb-img-000190
Figure PCTKR2022010379-appb-img-000190
질소 분위기에서 화합물 D-d-3(10 g, 39.4 mmol), 아민 20(17.4 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 53 15.6 g을 얻었다. (수율 62%, MS: [M+H]+= 639)In a nitrogen atmosphere, compound Dd-3 (10 g, 39.4 mmol), amine 20 (17.4 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.6 g of Compound 53. (Yield 62%, MS: [M+H] + = 639)
합성예 54Synthesis Example 54
Figure PCTKR2022010379-appb-img-000191
Figure PCTKR2022010379-appb-img-000191
질소 분위기에서 화합물 D-d-4(10 g, 39.4 mmol), 아민 33(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 3 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 54 15.2 g을 얻었다. (수율 58%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Dd-4 (10 g, 39.4 mmol), amine 33 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Thereafter, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 3 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 15.2 g of Compound 54. (Yield 58%, MS: [M+H] + = 665)
합성예 55Synthesis Example 55
Figure PCTKR2022010379-appb-img-000192
Figure PCTKR2022010379-appb-img-000192
질소 분위기에서 화합물 D-d-5(10 g, 39.4mmol), 아민 15(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 55 16.5 g을 얻었다. (수율 63%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound Dd-5 (10 g, 39.4 mmol), amine 15 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 16.5 g of Compound 55. (Yield 63%, MS: [M+H] + = 665)
합성예 56Synthesis Example 56
Figure PCTKR2022010379-appb-img-000193
Figure PCTKR2022010379-appb-img-000193
질소 분위기에서 화합물 D-e-2(10 g, 39.4 mmol), 아민 45(18.5 g, 41.4 mmol), 소듐 터트-부톡사이드(4.9 g, 51.2 mmol)를 자일렌(200 ml)에 넣고 교반 및 환류했다. 이 후 비스(트리-터트-부틸포스핀)팔라듐(0)(0.4 g, 0.8 mmol)을 투입했다. 2 시간 후 반응이 종결되어서 상온으로 식히고 감압하여 용매를 제거했다. 이 후 화합물을 다시 클로로포름에 완전히 녹이고 물로 2회 세척 후에 유기층을 분리하여 무수황산마그네슘 처리 후 여과하여 여액을 감압 증류했다. 농축한 화합물을 실리카 겔 컬럼 크로마토그래피로 정제해서 화합물 56 18.9 g을 얻었다. (수율 72%, MS: [M+H]+= 665)In a nitrogen atmosphere, compound De-2 (10 g, 39.4 mmol), amine 45 (18.5 g, 41.4 mmol), and sodium tert-butoxide (4.9 g, 51.2 mmol) were added to xylene (200 ml), stirred and refluxed. . Then, bis(tri-tert-butylphosphine)palladium(0) (0.4 g, 0.8 mmol) was added. After 2 hours, the reaction was completed, cooled to room temperature, and the solvent was removed under reduced pressure. Thereafter, the compound was completely dissolved again in chloroform, washed twice with water, and the organic layer was separated, treated with anhydrous magnesium sulfate, filtered, and the filtrate was distilled under reduced pressure. The concentrated compound was purified by silica gel column chromatography to obtain 18.9 g of compound 56. (Yield 72%, MS: [M+H] + = 665)
[실시예][Example]
실시예 1Example 1
ITO(indium tin oxide)가 1,000Å의 두께로 박막 코팅된 유리 기판을 세제를 녹인 증류수에 넣고 초음파로 세척했다. 이때, 세제로는 피셔사(Fischer Co.) 제품을 사용하였으며, 증류수로는 밀러포어사(Millipore Co.) 제품의 필터(Filter)로 2차로 걸러진 증류수를 사용했다. ITO를 30분간 세척한 후 증류수로 2회 반복하여 초음파 세척을 10분간 진행했다. 증류수 세척이 끝난 후, 이소프로필알콜, 아세톤, 메탄올의 용제로 초음파 세척을 하고 건조시킨 후 플라즈마 세정기로 수송시켰다. 또한, 산소 플라즈마를 이용하여 상기 기판을 5분간 세정한 후 진공 증착기로 기판을 수송시켰다.A glass substrate coated with indium tin oxide (ITO) with a thickness of 1,000 Å was put in distilled water in which detergent was dissolved and washed with ultrasonic waves. At this time, a Fischer Co. product was used as the detergent, and distilled water filtered through a second filter of a Millipore Co. product was used as the distilled water. After washing the ITO for 30 minutes, it was repeated twice with distilled water and ultrasonic cleaning was performed for 10 minutes. After washing with distilled water, ultrasonic cleaning was performed with solvents such as isopropyl alcohol, acetone, and methanol, dried, and transported to a plasma cleaner. In addition, after cleaning the substrate for 5 minutes using oxygen plasma, the substrate was transferred to a vacuum deposition machine.
이렇게 준비된 ITO 투명 전극 위에 정공주입층으로 하기 HI-1 화합물을 1150Å의 두께로 형성하되 하기 A-1 화합물을 1.5% 농도로 p-doping 했다. 상기 정공주입층 위에 하기 HT-1 화합물을 진공 증착하여 막 두께 800Å의 정공수송층을 형성했다. 이어서, 상기 정공수송층 위에 막 두께 150Å으로 하기 화합물 1을 진공 증착하여 제2 정공 수송층을 형성했다. 이어서, 상기 화합물 1 위에 호스트로 하기 RH-1 화합물, 도판트로 하기 Dp-7 화합물을 98:2의 중량비로 진공 증착하여 400Å 두께의 적색 발광층을 형성했다. 상기 발광층 위에 막 두께 30Å으로 하기 HB-1 화합물을 진공 증착하여 정공저지층을 형성했다. 이어서, 상기 정공저지층 위에 하기 ET-1 화합물과 하기 LiQ 화합물을 2:1의 중량비로 진공 증착하여 300Å의 두께로 전자 주입 및 수송층을 형성했다. 상기 전자 주입 및 수송층 위에 순차적으로 12Å 두께로 리튬플로라이드(LiF)와 1,000Å 두께로 알루미늄을 증착하여 음극을 형성했다. The following compound HI-1 was formed to a thickness of 1150 Å as a hole injection layer on the prepared ITO transparent electrode, but the following compound A-1 was p-doped at a concentration of 1.5%. On the hole injection layer, the following HT-1 compound was vacuum deposited to form a hole transport layer having a film thickness of 800 Å. Subsequently, a second hole transport layer was formed on the hole transport layer by vacuum depositing the following compound 1 to a film thickness of 150 Å. Then, on the compound 1, the following RH-1 compound as a host and the following Dp-7 compound as a dopant were vacuum deposited at a weight ratio of 98:2 to form a red light emitting layer having a thickness of 400 Å. A hole blocking layer was formed on the light emitting layer by vacuum depositing the following HB-1 compound to a film thickness of 30 Å. Subsequently, the following ET-1 compound and the following LiQ compound were vacuum deposited at a weight ratio of 2:1 on the hole blocking layer to form an electron injection and transport layer with a thickness of 300 Å. A negative electrode was formed by sequentially depositing lithium fluoride (LiF) to a thickness of 12 Å and aluminum to a thickness of 1,000 Å on the electron injection and transport layer.
Figure PCTKR2022010379-appb-img-000194
Figure PCTKR2022010379-appb-img-000194
상기의 과정에서 유기물의 증착속도는 0.4~0.7 Å/sec를 유지하였고, 음극의 리튬플로라이드는 0.3 Å/sec, 알루미늄은 2 Å/sec의 증착 속도를 유지하였으며, 증착시 진공도는 2×10-7 ~ 5×10-6 torr를 유지하여, 유기 발광 소자를 제작했다.In the above process, the deposition rate of the organic material was maintained at 0.4 to 0.7 Å/sec, the deposition rate of lithium fluoride on the anode was 0.3 Å/sec, and the deposition rate of aluminum was 2 Å/sec, and the vacuum level during deposition was 2×10 Maintaining -7 to 5×10 -6 torr, an organic light emitting device was fabricated.
실시예 2 내지 실시예 56Examples 2 to 56
실시예 1의 유기 발광 소자에서 화합물 1 대신 하기 표 1에 기재된 화합물을 사용하는 것을 제외하고는, 상기 실시예 1과 동일한 방법으로 유기 발광 소자를 제조했다. An organic light emitting device was manufactured in the same manner as in Example 1, except that the compound shown in Table 1 was used instead of Compound 1 in the organic light emitting device of Example 1.
비교예 1 내지 비교예 12Comparative Examples 1 to 12
실시예 1의 유기 발광 소자에서 화합물 1 대신 하기 표 1에 기재된 화합물을 사용하는 것을 제외하고는, 상기 비교예 1과 동일한 방법으로 유기 발광 소자를 제조했다. An organic light emitting device was manufactured in the same manner as in Comparative Example 1, except that the compound shown in Table 1 was used instead of Compound 1 in the organic light emitting device of Example 1.
Figure PCTKR2022010379-appb-img-000195
Figure PCTKR2022010379-appb-img-000195
상기 실시예 1 내지 실시예 56 및 비교예 1 내지 비교예 12에서 제조한 유기 발광 소자에 전류를 인가하였을 때, 전압, 효율을 측정(15mA/cm2)하고 그 결과를 하기 표 1 내지 표 4에 나타냈다. 수명 T95는 휘도가 초기 휘도(6000 nit)에서 95%로 감소되는데 소요되는 시간을 의미한다.When current was applied to the organic light emitting devices prepared in Examples 1 to 56 and Comparative Examples 1 to 12, voltage and efficiency were measured (15 mA/cm 2 ) and the results are shown in Tables 1 to 4 below. shown in The lifetime T95 means the time required for the luminance to decrease from the initial luminance (6000 nit) to 95%.
구분division 물질matter 구동전압(V)Driving voltage (V) 효율(cd/A)Efficiency (cd/A) 수명 T95(hr)Lifetime T95(hr) 발광색luminescent color
실시예 1Example 1 화합물 1 compound 1 3.78 3.78 18.1418.14 139139 적색Red
실시예 2Example 2 화합물 2 compound 2 3.67 3.67 19.8419.84 134134 적색Red
실시예 3Example 3 화합물 3 compound 3 3.73 3.73 19.7319.73 142142 적색Red
실시예 4Example 4 화합물 4 compound 4 3.76 3.76 19.2819.28 132132 적색Red
실시예 5Example 5 화합물 5 compound 5 3.76 3.76 18.8918.89 138138 적색Red
실시예 6Example 6 화합물 6 compound 6 3.72 3.72 19.1519.15 141141 적색Red
실시예 7Example 7 화합물 7 compound 7 3.77 3.77 18.2218.22 134134 적색Red
실시예 8Example 8 화합물 8 compound 8 3.66 3.66 18.2318.23 142142 적색Red
실시예 9Example 9 화합물 9compound 9 3.79 3.79 19.5319.53 139139 적색Red
실시예 10Example 10 화합물 10compound 10 3.79 3.79 19.7919.79 136136 적색Red
실시예 11Example 11 화합물 11compound 11 3.55 3.55 19.8519.85 148148 적색Red
실시예 12Example 12 화합물 12compound 12 3.53 3.53 23.3423.34 163163 적색Red
실시예 13Example 13 화합물 13compound 13 3.59 3.59 24.0724.07 159159 적색Red
실시예 14Example 14 화합물 14compound 14 3.54 3.54 22.6622.66 139139 적색Red
실시예 15Example 15 화합물 15compound 15 3.53 3.53 21.4621.46 154154 적색Red
실시예 16Example 16 화합물 16compound 16 3.53 3.53 24.1824.18 136136 적색Red
실시예 17Example 17 화합물 17compound 17 3.58 3.58 22.7922.79 160160 적색Red
실시예 18Example 18 화합물 18compound 18 3.56 3.56 22.3122.31 147147 적색Red
실시예 19Example 19 화합물 19compound 19 3.55 3.55 22.9022.90 128128 적색Red
실시예 20Example 20 화합물 20compound 20 3.58 3.58 21.0821.08 136136 적색Red
구분division 물질matter 구동전압(V)Driving voltage (V) 효율(cd/A)Efficiency (cd/A) 수명 T95(hr)Lifetime T95(hr) 발광색luminescent color
실시예 21Example 21 화합물 21compound 21 3.52 3.52 21.6521.65 194194 적색Red
실시예 22Example 22 화합물 22compound 22 3.53 3.53 21.9921.99 189189 적색Red
실시예 23Example 23 화합물 23compound 23 3.50 3.50 21.6621.66 185185 적색Red
실시예 24Example 24 화합물 24compound 24 3.45 3.45 21.3421.34 194194 적색Red
실시예 25Example 25 화합물 25compound 25 3.53 3.53 21.9721.97 191191 적색Red
실시예 26Example 26 화합물 26compound 26 3.49 3.49 22.0822.08 189189 적색Red
실시예 27Example 27 화합물 27compound 27 3.53 3.53 21.7821.78 195195 적색Red
실시예 28Example 28 화합물 28compound 28 3.46 3.46 21.5121.51 201201 적색Red
실시예 29Example 29 화합물 29compound 29 3.48 3.48 21.7221.72 193193 적색Red
실시예 30Example 30 화합물 30compound 30 3.49 3.49 21.2621.26 188188 적색Red
실시예 31Example 31 화합물 31compound 31 3.60 3.60 21.5221.52 170170 적색Red
실시예 32Example 32 화합물 32compound 32 3.64 3.64 21.6221.62 179179 적색Red
실시예 33Example 33 화합물 33compound 33 3.63 3.63 20.9320.93 177177 적색Red
실시예 34Example 34 화합물 34compound 34 3.67 3.67 21.2821.28 184184 적색Red
실시예 35Example 35 화합물 35compound 35 3.59 3.59 21.5121.51 171171 적색Red
실시예 36Example 36 화합물 36compound 36 3.67 3.67 20.5420.54 166166 적색Red
실시예 37Example 37 화합물 37compound 37 3.63 3.63 21.3021.30 176176 적색Red
실시예 38Example 38 화합물 38compound 38 3.65 3.65 20.3820.38 163163 적색Red
실시예 39Example 39 화합물 39compound 39 3.68 3.68 21.2621.26 185185 적색Red
실시예 40Example 40 화합물 40compound 40 3.68 3.68 21.5721.57 183183 적색Red
구분division 물질matter 구동전압(V)Driving voltage (V) 효율(cd/A)Efficiency (cd/A) 수명 T95(hr)Lifetime T95(hr) 발광색luminescent color
실시예 41Example 41 화합물 41compound 41 3.65 3.65 18.3118.31 130130 적색Red
실시예 42Example 42 화합물 42compound 42 3.65 3.65 18.9318.93 142142 적색Red
실시예 43Example 43 화합물 43compound 43 3.78 3.78 18.8518.85 140140 적색Red
실시예 44Example 44 화합물 44compound 44 3.68 3.68 19.3319.33 129129 적색Red
실시예 45Example 45 화합물 45compound 45 3.70 3.70 18.0518.05 133133 적색Red
실시예 46Example 46 화합물 46compound 46 3.69 3.69 19.2919.29 131131 적색Red
실시예 47Example 47 화합물 47compound 47 3.77 3.77 19.8519.85 132132 적색Red
실시예 48Example 48 화합물 48compound 48 3.75 3.75 19.2119.21 129129 적색Red
실시예 49Example 49 화합물 49compound 49 3.73 3.73 18.8818.88 132132 적색Red
실시예 50Example 50 화합물 50compound 50 3.70 3.70 19.3819.38 137137 적색Red
실시예 51Example 51 화합물 51compound 51 3.66 3.66 21.1021.10 179179 적색Red
실시예 52Example 52 화합물 52compound 52 3.67 3.67 21.6521.65 180180 적색Red
실시예 53Example 53 화합물 53compound 53 3.59 3.59 21.0721.07 182182 적색Red
실시예 54Example 54 화합물 54compound 54 3.59 3.59 20.5220.52 166166 적색Red
실시예 55Example 55 화합물 55compound 55 3.61 3.61 21.2221.22 164164 적색Red
실시예 56Example 56 화합물 56compound 56 3.65 3.65 21.7021.70 171171 적색Red
구분division 물질matter 구동전압(V)Driving voltage (V) 효율(cd/A)Efficiency (cd/A) 수명 T95(hr)Lifetime T95(hr) 발광색luminescent color
비교예 1Comparative Example 1 C-1C-1 4.16 4.16 15.5115.51 107107 적색Red
비교예 2Comparative Example 2 C-2C-2 4.03 4.03 15.8715.87 9292 적색Red
비교예 3Comparative Example 3 C-3C-3 4.12 4.12 15.1115.11 9797 적색Red
비교예 4Comparative Example 4 C-4C-4 3.96 3.96 17.1117.11 8181 적색Red
비교예 5Comparative Example 5 C-5C-5 3.92 3.92 17.0017.00 8686 적색Red
비교예 6Comparative Example 6 C-6C-6 3.983.98 16.7016.70 104104 적색Red
비교예 7Comparative Example 7 C-7C-7 4.05 4.05 15.7015.70 9494 적색Red
비교예 8Comparative Example 8 C-8C-8 3.95 3.95 17.1517.15 8282 적색Red
비교예 9Comparative Example 9 C-9C-9 3.93 3.93 17.1317.13 104104 적색Red
비교예 10Comparative Example 10 C-10C-10 4.16 4.16 13.5113.51 6363 적색Red
비교예 11Comparative Example 11 C-11C-11 4.14 4.14 12.8712.87 2424 적색Red
비교예 12Comparative Example 12 C-12C-12 4.21 4.21 10.1110.11 1717 적색Red
실시예 1 내지 56 및 비교예 1 내지 12에 의해 제작된 유기 발광 소자에 전류를 인가하였을 때, 상기 표 1 내지 표 4의 결과를 얻었다. 상기 실시예 1의 적색 유기 발광 소자는 종래 널리 사용되고 있는 물질을 사용하였으며, 적색 발광층의 도판트로 Dp-7을 사용하는 구조이다. 비교예 1 내지 14은 화합물 1 대신 C-1 내지 C-12를 사용하여 유기 발광 소자를 제조했다. 상기 표 1 내지 표 4의 결과를 보면 본 발명의 화합물이 제2 정공 수소층으로 사용했을 때 비교예 물질에 비해서 구동 전압이 크게 낮아졌으며, 효율 측면에서도 상승을 한 것으로 보아 호스트에서 적색 도판트로의 에너지 전달이 잘 이뤄진다는 것을 알 수 있었다. 또한 높은 효율을 유지하면서도 수명 특성을 크게 개선시킬 수 있는 것을 알 수 있었다. 이것은 결국 비교예 화합물 보다 본 발명의 화합물이 전자와 정공에 대한 안정도가 높기 때문이라 판단 할 수 있다. 결론적으로 본 발명의 화합물을 제2 정공 수송층으로 사용하였을 때 유기 발광 소자의 구동전압, 발광 효율 및 수명 특성을 개선할 수 있다는 것을 확인할 수 있다. When current was applied to the organic light emitting devices manufactured in Examples 1 to 56 and Comparative Examples 1 to 12, the results of Tables 1 to 4 were obtained. The red organic light emitting device of Example 1 uses materials widely used in the prior art, and has a structure in which Dp-7 is used as a dopant for the red light emitting layer. In Comparative Examples 1 to 14, organic light emitting diodes were prepared using C-1 to C-12 instead of Compound 1. Looking at the results of Tables 1 to 4, when the compound of the present invention was used as the second hole hydrogen layer, the driving voltage was significantly lowered compared to the comparative example material, and the efficiency was also increased, so that the host to the red dopant It was found that the energy transfer was well done. In addition, it was found that the lifetime characteristics can be greatly improved while maintaining high efficiency. It can be determined that this is because the compound of the present invention has higher electron and hole stability than the comparative compound. In conclusion, it can be confirmed that the driving voltage, luminous efficiency and lifetime characteristics of the organic light emitting device can be improved when the compound of the present invention is used as the second hole transport layer.
[부호의 설명][Description of code]
1: 기판 2: 양극1: substrate 2: anode
3: 발광층 4: 음극3: light emitting layer 4: cathode
5: 정공주입층 6: 정공수송층5: hole injection layer 6: hole transport layer
7: 발광층 8: 전자주입 및 수송층7: light emitting layer 8: electron injection and transport layer

Claims (10)

  1. 하기 화학식 1로 표시되는 화합물:A compound represented by Formula 1 below:
    [화학식 1] [Formula 1]
    Figure PCTKR2022010379-appb-img-000196
    Figure PCTKR2022010379-appb-img-000196
    상기 화학식 1에서, In Formula 1,
    X1 내지 X10 중 하나는 N이고, 나머지는 CR1이고,One of X 1 to X 10 is N, the other is CR 1 ,
    R1 중 하나는 하기 화학식 2로 표시되는 치환기이고, 나머지는 수소, 또는 중수소이고, One of R 1 is a substituent represented by Formula 2 below, the others are hydrogen or deuterium,
    [화학식 2][Formula 2]
    Figure PCTKR2022010379-appb-img-000197
    Figure PCTKR2022010379-appb-img-000197
    상기 화학식 2에서,In Formula 2,
    L1은 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이고,L 1 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
    L2는 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이고,L 2 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
    L3는 직접 결합; 치환 또는 비치환된 C6-60 아릴렌; 또는 치환 또는 비치환된 C5-60 헤테로아릴렌이고,L 3 is a direct bond; Substituted or unsubstituted C 6-60 arylene; or a substituted or unsubstituted C 5-60 heteroarylene;
    Ar1은 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된 C5-60 헤테로아릴이고,Ar 1 is a substituted or unsubstituted C 6-60 aryl; or a substituted or unsubstituted C 5-60 heteroaryl;
    Ar2는 치환 또는 비치환된 C6-60 아릴; 또는 치환 또는 비치환된 C5-60 헤테로아릴이다. Ar 2 is a substituted or unsubstituted C 6-60 aryl; Or a substituted or unsubstituted C 5-60 heteroaryl.
  2. 제1항에 있어서, According to claim 1,
    L1은 직접 결합; 또는 페닐렌인,L 1 is a direct bond; or phenylene,
    화합물.compound.
  3. 제1항에 있어서, According to claim 1,
    L2는 직접 결합; 페닐렌; 터페닐릴렌; 비페닐릴렌; 9,9-디메틸플루오레닐렌; 9,9-디페닐플루오레닐렌; 또는 나프틸렌인,L 2 is a direct bond; phenylene; terphenylylene; biphenylylene; 9,9-dimethylfluorenylene; 9,9-diphenylfluorenylene; or naphthylene,
    화합물.compound.
  4. 제1항에 있어서, According to claim 1,
    L3는 직접 결합; 페닐렌; 터페닐릴렌; 비페닐릴렌; 9,9-디메틸-플루오레닐렌; 9,9-디페닐-플루오레닐렌; 또는 나프틸렌인,L 3 is a direct bond; phenylene; terphenylylene; biphenylylene; 9,9-dimethyl-fluorenylene; 9,9-diphenyl-fluorenylene; or naphthylene,
    화합물.compound.
  5. 제1항에 있어서, According to claim 1,
    Ar1는 페닐; 비페닐릴; 터페닐릴; 나프틸; 페난트렌; (페닐)나프틸; (나프틸)페닐; 9,9-디메틸플루오레닐; 9,9-디페닐플루오레닐; 9,9’-스피로비[9H-플루오렌]일; 디벤조퓨라닐; 디벤조싸이오페닐; 9-페닐-카바졸일; 또는 9-나프틸-카르바졸일인,Ar 1 is phenyl; biphenylyl; terphenylyl; naphthyl; phenanthrene; (phenyl) naphthyl; (naphthyl)phenyl; 9,9-dimethylfluorenyl; 9,9-diphenylfluorenyl; 9,9'-spirobi[9H-fluorene]yl;dibenzofuranyl;dibenzothiophenyl;9-phenyl-carbazolyl; or 9-naphthyl-carbazolyl;
    화합물.compound.
  6. 제1항에 있어서, According to claim 1,
    Ar2는 페닐; 비페닐릴; 터페닐릴; 나프틸; 페난트렌; (페닐)나프틸; (나프틸)페닐; 9,9-디메틸-플루오레닐; 9,9-디페닐-플루오레닐; 9,9’-스피로비[9H-플루오렌]일; 디벤조퓨라닐; 디벤조싸이오페닐; 9-페닐-카바졸일; 또는 9-나프틸-카르바졸일인,Ar 2 is phenyl; biphenylyl; terphenylyl; naphthyl; phenanthrene; (phenyl) naphthyl; (naphthyl)phenyl; 9,9-dimethyl-fluorenyl; 9,9-diphenyl-fluorenyl; 9,9'-spirobi[9H-fluorene]yl;dibenzofuranyl;dibenzothiophenyl;9-phenyl-carbazolyl; or 9-naphthyl-carbazolyl;
    화합물.compound.
  7. 제1항에 있어서, According to claim 1,
    상기 화학식 1에서 X1 내지 X4 중 하나에 화학식 2로 표시되는 CR1이 부착되는 것인,CR 1 represented by Formula 2 is attached to one of X 1 to X 4 in Formula 1,
    화합물.compound.
  8. 제1항에 있어서, According to claim 1,
    상기 화학식 1로 표시되는 화합물은 하기로 구성되는 군으로부터 선택되는 어느 하나인,The compound represented by Formula 1 is any one selected from the group consisting of
    화합물:compound:
    Figure PCTKR2022010379-appb-img-000198
    Figure PCTKR2022010379-appb-img-000198
    Figure PCTKR2022010379-appb-img-000199
    Figure PCTKR2022010379-appb-img-000199
    Figure PCTKR2022010379-appb-img-000200
    Figure PCTKR2022010379-appb-img-000200
    Figure PCTKR2022010379-appb-img-000201
    Figure PCTKR2022010379-appb-img-000201
    Figure PCTKR2022010379-appb-img-000202
    Figure PCTKR2022010379-appb-img-000202
    Figure PCTKR2022010379-appb-img-000203
    Figure PCTKR2022010379-appb-img-000203
    Figure PCTKR2022010379-appb-img-000204
    Figure PCTKR2022010379-appb-img-000204
    Figure PCTKR2022010379-appb-img-000205
    Figure PCTKR2022010379-appb-img-000205
    Figure PCTKR2022010379-appb-img-000206
    Figure PCTKR2022010379-appb-img-000206
    Figure PCTKR2022010379-appb-img-000207
    Figure PCTKR2022010379-appb-img-000207
    Figure PCTKR2022010379-appb-img-000208
    Figure PCTKR2022010379-appb-img-000208
    Figure PCTKR2022010379-appb-img-000209
    Figure PCTKR2022010379-appb-img-000209
    Figure PCTKR2022010379-appb-img-000210
    Figure PCTKR2022010379-appb-img-000210
    Figure PCTKR2022010379-appb-img-000211
    Figure PCTKR2022010379-appb-img-000211
    Figure PCTKR2022010379-appb-img-000212
    Figure PCTKR2022010379-appb-img-000212
    Figure PCTKR2022010379-appb-img-000213
    Figure PCTKR2022010379-appb-img-000213
    Figure PCTKR2022010379-appb-img-000214
    Figure PCTKR2022010379-appb-img-000214
    Figure PCTKR2022010379-appb-img-000215
    Figure PCTKR2022010379-appb-img-000215
    Figure PCTKR2022010379-appb-img-000216
    Figure PCTKR2022010379-appb-img-000216
    Figure PCTKR2022010379-appb-img-000217
    Figure PCTKR2022010379-appb-img-000217
    Figure PCTKR2022010379-appb-img-000218
    Figure PCTKR2022010379-appb-img-000218
    Figure PCTKR2022010379-appb-img-000219
    Figure PCTKR2022010379-appb-img-000219
    Figure PCTKR2022010379-appb-img-000220
    Figure PCTKR2022010379-appb-img-000220
    Figure PCTKR2022010379-appb-img-000221
    Figure PCTKR2022010379-appb-img-000221
    Figure PCTKR2022010379-appb-img-000222
    Figure PCTKR2022010379-appb-img-000222
    Figure PCTKR2022010379-appb-img-000223
    Figure PCTKR2022010379-appb-img-000223
    Figure PCTKR2022010379-appb-img-000224
    Figure PCTKR2022010379-appb-img-000224
    Figure PCTKR2022010379-appb-img-000225
    Figure PCTKR2022010379-appb-img-000225
    Figure PCTKR2022010379-appb-img-000226
    Figure PCTKR2022010379-appb-img-000226
    Figure PCTKR2022010379-appb-img-000227
    Figure PCTKR2022010379-appb-img-000227
    Figure PCTKR2022010379-appb-img-000228
    Figure PCTKR2022010379-appb-img-000228
    Figure PCTKR2022010379-appb-img-000229
    Figure PCTKR2022010379-appb-img-000229
    Figure PCTKR2022010379-appb-img-000230
    Figure PCTKR2022010379-appb-img-000230
    Figure PCTKR2022010379-appb-img-000231
    Figure PCTKR2022010379-appb-img-000231
  9. 제1 전극; 상기 제1 전극과 대향하여 구비된 제2 전극; 및 상기 제1 전극과 상기 제2 전극 사이에 구비된 유기물층을 포함하는 유기 발광 소자로서, 상기 유기물층은 제1항 내지 제8항 중 어느 하나의 항에 따른 화합물을 포함하는 것인, 유기 발광 소자.a first electrode; a second electrode provided to face the first electrode; and an organic material layer provided between the first electrode and the second electrode, wherein the organic material layer includes the compound according to any one of claims 1 to 8. .
  10. 제9항에 있어서, According to claim 9,
    상기 화합물을 포함하는 유기물층은 전자발광층인,The organic material layer containing the compound is an electroluminescent layer,
    유기 발광 소자.organic light emitting device.
PCT/KR2022/010379 2021-07-15 2022-07-15 Novel compound and organic light-emitting device comprising same WO2023287252A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202280011343.0A CN116964060A (en) 2021-07-15 2022-07-15 Novel compound and organic light emitting device comprising the same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20210093023 2021-07-15
KR10-2021-0093023 2021-07-15
KR1020220087408A KR20230012442A (en) 2021-07-15 2022-07-15 Novel compound and organic light emitting device comprising the same
KR10-2022-0087408 2022-07-15

Publications (1)

Publication Number Publication Date
WO2023287252A1 true WO2023287252A1 (en) 2023-01-19

Family

ID=84919555

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/010379 WO2023287252A1 (en) 2021-07-15 2022-07-15 Novel compound and organic light-emitting device comprising same

Country Status (1)

Country Link
WO (1) WO2023287252A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010137285A1 (en) * 2009-05-29 2010-12-02 出光興産株式会社 Anthracene derivative and organic electroluminescent element using the same
KR20130127567A (en) * 2012-05-03 2013-11-25 삼성디스플레이 주식회사 A condensed-cyclic compound and an organic light emitting diode comprising the same
KR20160001702A (en) * 2014-06-27 2016-01-06 희성소재 (주) Hetero-cyclic compound and organic light emitting device using the same
KR20160018458A (en) * 2013-06-11 2016-02-17 이데미쓰 고산 가부시키가이샤 Material for organic electroluminescent elements, organic electroluminescent element using same, and electronic device
KR20200046229A (en) * 2018-10-23 2020-05-07 덕산네오룩스 주식회사 Compound for organic electric element, organic electric element comprising the same and electronic device thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010137285A1 (en) * 2009-05-29 2010-12-02 出光興産株式会社 Anthracene derivative and organic electroluminescent element using the same
KR20130127567A (en) * 2012-05-03 2013-11-25 삼성디스플레이 주식회사 A condensed-cyclic compound and an organic light emitting diode comprising the same
KR20160018458A (en) * 2013-06-11 2016-02-17 이데미쓰 고산 가부시키가이샤 Material for organic electroluminescent elements, organic electroluminescent element using same, and electronic device
KR20160001702A (en) * 2014-06-27 2016-01-06 희성소재 (주) Hetero-cyclic compound and organic light emitting device using the same
KR20200046229A (en) * 2018-10-23 2020-05-07 덕산네오룩스 주식회사 Compound for organic electric element, organic electric element comprising the same and electronic device thereof

Similar Documents

Publication Publication Date Title
WO2016195441A1 (en) Nitrogen-containing condensed cyclic compound and organic light emitting element using same
WO2021182775A1 (en) Organic light-emitting device
WO2020153713A1 (en) Compound and organic light-emitting element comprising same
WO2021096228A1 (en) Organic light emitting device
WO2021210911A1 (en) Novel compound and organic light-emitting element comprising same
WO2022039520A1 (en) Novel compound and organic light-emitting device comprising same
WO2021029616A1 (en) Organic light-emitting device
WO2021221475A1 (en) Organic light-emitting device
WO2022086168A1 (en) Organic light-emitting device
WO2020141949A1 (en) Novel compound and organic light emitting device using same
WO2022080715A1 (en) Novel compound and organic light-emitting device comprising same
WO2021096331A1 (en) Organic light-emitting diode
WO2020222569A1 (en) Organic light-emitting device
WO2020159333A1 (en) Compound and organic light emitting device comprising same
WO2022086171A1 (en) Organic light-emitting device
WO2022045743A1 (en) Novel compound and organic light-emitting device using same
WO2021210910A1 (en) Novel compound and organic light emitting device using same
WO2021261962A1 (en) Organic light-emitting device
WO2020263000A1 (en) Novel compound and organic light emitting device using same
WO2020159335A1 (en) Compound and organic light emitting diode comprising same
WO2023287252A1 (en) Novel compound and organic light-emitting device comprising same
WO2023287255A1 (en) Novel compound and organic light-emitting device using same
WO2018048247A1 (en) Compound and organic electronic element comprising same
WO2023063761A1 (en) Novel compound and organic light-emitting device using same
WO2022177288A1 (en) Novel compound and organic light emitting device comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22842514

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 202280011343.0

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE